The emerging hallmarks of cancer metabolism
Open accessAbstract
Tumorigenesis is dependent on the reprogramming of cellular metabolism as both direct and indirect consequence of oncogenic mutations. A common feature of cancer cell metabolism is the ability to acquire necessary nutrients from a frequently nutrient-poor environment and utilize these nutrients to both maintain viability and build new biomass. The alterations in intracellular and extracellular metabolites that can accompany cancer-associated metabolic reprogramming have profound effects on gene expression, cellular differentiation and the tumor microenvironment. In this Review, we have organized known cancer-associated metabolic changes into six hallmarks: (1) deregulated uptake of glucose and amino acids, (2) use of opportunistic modes of nutrient acquisition, (3) use of glycolysis/TCA cycle intermediates for biosynthesis and NADPH production, (4) increased demand for nitrogen, (5) alterations in metabolite-driven gene regulation, and (6) metabolic interactions with the microenvironment. While few tumors display all six hallmarks, most display several. The specific hallmarks exhibited by an individual tumor may ultimately contribute to better tumor classification and aid in directing treatment.
Verified 2026-10-09 · 1 reference not checked yet
AI snapshot
Written from the paper’s full text.
TL;DR
This review organizes known cancer-associated metabolic changes into six hallmarks: deregulated uptake of glucose and amino acids, opportunistic modes of nutrient acquisition, use of glycolysis/TCA cycle intermediates for biosynthesis and NADPH production, increased demand for nitrogen, alterations in metabolite-driven gene regulation, and metabolic interactions with the microenvironment. The authors argue that while few tumors display all six hallmarks, most display several, and the specific hallmarks exhibited may aid tumor classification and treatment direction.
Key findings
- Cancer cells acquire nutrients through oncogene-driven constitutive uptake: PI3K/Akt signaling promotes GLUT1 expression and translocation and potentiates hexokinase and phosphofructokinase, while c-myc drives glutamine transporter (ASCT2, SN2) and glutaminase (GLS1) expression; Rb loss upregulates ASCT2 and GLS1 via E2F.
- Opportunistic nutrient acquisition allows survival under scarcity: Ras- or c-Src-driven macropinocytosis enables lysosomal degradation of extracellular protein (albumin at 20–30 mg/mL supports KRASG12D MEF proliferation without leucine), and mTORC1 inhibitors enhance this route — rapamycin suppresses proliferation at the tumor margin but enhances it in the poorly vascularized tumor core.
- Proliferating cells divert glycolytic intermediates into biosynthesis: cancer cells may use as much as 50% of glucose-derived carbon for serine biosynthesis, and stepwise oxidation of one-carbon-THF species can produce up to 50% of cellular NADPH; PKM2 (rather than PKM1) predominates in essentially all cancer cells and is inhibited by tyrosine phosphorylation and activated by serine.
- Metabolite-driven gene regulation links metabolism to epigenetics: mutant IDH1/IDH2 produce 2-HG that competitively inhibits α-ketoglutarate-dependent dioxygenases, and SDH/FH loss accumulates succinate/fumarate, all producing hypermethylation phenotypes; lactate accumulation promotes M2 macrophage polarization, angiogenesis, and immune-permissive microenvironments.
Methods
- Narrative review/Perspective synthesizing published literature on cancer metabolism; the authors state they organize known cancer-associated metabolic changes into six hallmarks.
- No primary data, sample, or statistical analysis is reported; evidence is drawn from cited studies across cell lines, mouse models, patient samples, and clinical imaging (e.g., 18F-FDG and 18F-glutamine PET).
- Not stated in the paper for any systematic search strategy, inclusion criteria, or quantitative synthesis.
Limitations
- The paper states that most studies to date have focused on glucose and glutamine metabolism, and that the contributions of other nutrients (sulfur-containing amino acids, essential fatty acids, choline, trace metals, vitamins, and microbiota-derived metabolites) are only beginning to be understood.
- The paper notes that cell lineage context and potential secondary effects of adaptation to tissue culture conditions may influence findings such as the choice of anaplerotic substrate (glutamine vs. glucose-derived pyruvate carboxylation).
- Evident from the text: as a narrative review without primary data or systematic methodology, the six-hallmark framework is an organizing proposal rather than an empirically validated classification, and the authors state that few tumors display all six hallmarks.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 254 cited sources checked · 0 supported · 0 flagged
- Interpretationnone given
Tumorigenesis depends on reprogramming cellular metabolism as a direct and indirect consequence of oncogenic mutations.
“Tumorigenesis is dependent on the reprogramming of cellular metabolism as both direct and indirect consequence of oncogenic mutations.”
Quote in the paperNot a substantial claim - Premisecitation
Intracellular glutamine may facilitate import of a broad range of LAT1 substrates including leucine, isoleucine, valine, methionine, tyrosine, tryptophan, and phenylalanine.
“In such a manner, intracellular glutamine may facilitate the import of a broad range of LAT1 substrates, including leucine, isoleucine, valine, methionine, tyrosine, tryptophan and phenylalanine”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Yanagida et al., 2001 source
Not checked in the free run.
- Premisecitation
Growth factor-deprived hematopoietic and neuronal cells fail to consume glucose in quantities sufficient to maintain cellular bioenergetics.
“when deprived of growth factors, hematopoietic and neuronal cells fail to consume glucose in quantities sufficient to even maintain cellular bioenergetics”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
Optimal growth of cultured HeLa cells requires a 10- to 100-fold molar excess of glutamine relative to other amino acids.
“the optimal growth of cultured HeLa cells requires a 10- to a 100-fold molar excess of glutamine in culture medium relative to other amino acids”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Eagle, 1955 source
Not checked in the free run.
- Premisereasoning
Glutamine provides nitrogen for biosynthesis of purine and pyrimidine nucleotides, glucosamine-6-phosphate, and non-essential amino acids.
“Thus, glutamine provides the nitrogen required for the biosynthesis of purine and pyrimidine nucleotides, glucosamine-6-phosphate, as well as non-essential amino acids.”
Quote in the paperNot a substantial claim
- Premisecitation
Glutamine is the most rapidly consumed amino acid by Ehrlich ascites carcinomas and several hepatomas and carcinosarcomas proliferating in vivo.
“glutamine was found to be the most rapidly consumed amino acid by Ehrlich ascites carcinomas as well as by a number of hepatomas and carcinosarcomas proliferating in vivo”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Marquez et al., 1989 source
Not checked in the free run.
- cites Sauer et al., 1982
Not checked in the free run.
- Premisenone given
Glutamine contributes carbon and reduced nitrogen for de novo biosynthesis of nitrogen-containing compounds.
“Glutamine, a second principal growth-supporting substrate contributes not only carbon, but also reduced nitrogen for the de novo biosynthesis of a number of diverse nitrogen-containing compounds.”
Quote in the paperSubstantial claim - Premisecitation
Numerous tumorigenic contexts are associated with depletion of glutamine from the tumor environment compared to normal tissue.
“numerous tumorigenic contexts are associated with the depletion of glutamine from the tumor environment as compared to the corresponding normal tissue”
Quote in the paperSubstantial claim0 of 3 sources checked - Interpretationnone given
Alterations in intracellular and extracellular metabolites accompanying cancer metabolic reprogramming have profound effects on gene expression, cellular differentiation, and the tumor microenvironment.
“The alterations in intracellular and extracellular metabolites that can accompany cancer-associated metabolic reprogramming have profound effects on gene expression, cellular differentiation and the tumor microenvironment.”
Quote in the paperNot a substantial claim - Premisereasoning
Catabolism of glucose and glutamine maintains pools of carbon intermediates used as building blocks for macromolecules.
“Through the catabolism of glucose and glutamine, a cell maintains pools of diverse carbon intermediates, which are utilized as building blocks for the assembly of various macromolecules.”
Quote in the paperSubstantial claim - Premisecitation
Import of leucine through LAT1 is coupled to simultaneous efflux of glutamine.
“the import of an essential amino acid leucine through the plasma membrane-localized neutral amino acid antiporter LAT1 was shown to be coupled to a simultaneous efflux of glutamine”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Nicklin et al., 2009 source
Not checked in the free run.
- Premisecitation
Markedly increased glucose consumption by tumors compared to non-proliferating normal tissues was first described by Warburg.
“A markedly increased consumption of glucose by tumors in comparison to the non-proliferating normal tissues was first described more than 90 years ago by the German physiologist Otto Warburg”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Warburg O, 1924
Not checked in the free run.
- cites Warburg et al., 1927 source
Not checked in the free run.
- Premisecitation
Survival of growth-factor deprived cells can be restored by combined expression of GLUT1 and hexokinase.
“survival of growth-factor deprived cells can be readily restored by a combined expression of a plasma membrane glucose transporter GLUT1 and the first enzyme of the glycolytic pathway hexokinase (HK)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Rathmell et al., 2003 source
Not checked in the free run.
- Interpretationnone given
A common feature of cancer cell metabolism is the ability to acquire necessary nutrients from a nutrient-poor environment and use them to maintain viability and build biomass.
“A common feature of cancer cell metabolism is the ability to acquire necessary nutrients from a frequently nutrient-poor environment and utilize these nutrients to both maintain viability and build new biomass.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Reprogramming of carbon metabolism by proliferating cells provides part of the explanation for Warburg's original observations.
“The reprogramming of carbon metabolism by proliferating cells provides part of the explanation for Warburg’s original observations concerning cancer metabolism.”
Quote in the paperSubstantial claim - Premisecitation
Targeted depletion of mitochondrial DNA reduces the tumorigenic potential of cancer cell lines in vitro and in vivo.
“targeted depletion of mitochondrial DNA reduces the tumorigenic potential of cancer cell lines in vitro and in vivo”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Cavalli et al., 1997
Not checked in the free run.
- cites Morais et al., 1994
Not checked in the free run.
- cites Tan et al., 2015 source
Not checked in the free run.
- Premisenone given
The major use of reduced carbon in proliferating cells is biosynthesis of biomolecules including fatty acids, cholesterol, pentose and hexose sugar derivatives, glycerol, nucleotides, and non-essential amino acids.
“The major use of reduced carbon in proliferating cells is for the biosynthesis of a diverse array of biomolecules – among which are fatty acids and cholesterol, pentose and hexose sugar derivatives, glycerol, nucleotides and non-essential amino acids.”
Quote in the paperSubstantial claim - Interpretationreasoning
Aberrantly activated oncogenes and/or loss of tumor suppressors can lock cancer cells in a state of constitutive scavenging of glucose, glutamine, and essential amino acids, enabling uncontrolled proliferation.
“aberrantly activated oncogenes and/or loss of tumor suppressors can lock cancer cells in a state where they constitutively scavenge available glucose, glutamine and essential amino acids from the extracellular environment, which, in turn, enables their uncontrolled proliferation.”
Quote in the paperSubstantial claim - Premisecitation
Expression of mutant Ras or c-Src provides a mechanism to recover free amino acids through lysosomal degradation of extracellular proteins.
“expression of mutant Ras or c-Src alleles provides cells with a mechanism that allows them to recover free amino acids through the lysosomal degradation of extracellular proteins”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Commisso et al., 2013 source
Not checked in the free run.
- Premisereasoning
Lack of vascular nutrient delivery in growing tumors causes hypoxic areas, suppressing biosynthetic reactions requiring molecular oxygen.
“A second consequence of a lack of vascular nutrient delivery in growing tumors is an emergence of hypoxic areas, which leads to a suppression of a number of biosynthetic reactions that require molecular oxygen as an electron acceptor.”
Quote in the paperSubstantial claim - Premisecitation
Cancer cells accumulate oncogenic alterations that convey significant independence from external requirements for survival and proliferation.
“cancer cells accumulate oncogenic alterations that convey to them a significant degree of independence from these external requirements”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Hanahan and Weinberg, 2000 source
Not checked in the free run.
- cites Vogelstein and Kinzler, 2004
Not checked in the free run.
- Premisenone given
Proliferating cells have only a modest increase in ATP consumption relative to their need for precursor molecules and NADPH.
“proliferating cells have only a modest increase in their consumption of ATP relative to their need for precursor molecules and reducing equivalents in the form of NADPH.”
Quote in the paperSubstantial claim - Interpretationreasoning
Glucose influx into cells is not driven by immediate bioenergetic needs but is rationed by extracellular stimuli.
“Taken together, these observations suggest that the influx of glucose into cells is not driven by the immediate bioenergetic needs of a cell, but on the contrary, is rationed strictly as a result of extracellular stimuli.”
Quote in the paperSubstantial claim - Premisecitation
Warburg demonstrated with tumor slices ex vivo that despite massive glucose consumption and ambient oxygen, cancer cells did not use the bioenergetic benefits of coupling glycolysis to the TCA cycle and converted surplus pyruvate to lactate.
“Warburg demonstrated that despite consuming massive amounts of glucose and being exposed to ambient oxygen, cancer cells did not take advantage of the bioenergetic benefits offered by the coupling of glycolysis to the TCA cycle. On the contrary, when grown in glucose-rich medium, any cells converted the surplus pyruvate to lactate, which, in turn, was secreted into the extracellular environment.”
Quote in the paperSubstantial claim - Premisereasoning
TCA cycle activity generating NADH and ATP is a major negative regulator of glucose metabolism.
“TCA cycle activity which generates NADH and ATP is the major negative regulator of glucose metabolism.”
Quote in the paperSubstantial claim - Premisecitation
Albumin supplementation restores proliferation of a KRASG12D-driven mouse pancreatic cancer line in medium devoid of all free amino acids.
“Albumin supplementation has even been shown to restore the proliferation of a KRASG12D-driven mouse pancreatic cancer line in the culture medium that was devoid of all free amino acids”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Kamphorst et al., 2015 source
Not checked in the free run.
- Premisecitation
Upregulation of FABP4 on metastatic ovarian cancer cells allows acquisition of fatty acids from omental adipocytes.
“upregulation of a long chain fatty acid-binding protein FABP4 on the surface of metastatic ovarian cancer cells allows them to acquire fatty acids directly from the adipocytes of the omental fat”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Nieman et al., 2011 source
Not checked in the free run.
- Premisecitation
Deletion of Atg7 changes lung tumors driven by KrasG12D and BrafV600E from malignant adenocarcinomas to benign oncocytomas.
“deletion of a core component of the autophagy machinery, Atg7, was shown to dramatically change the nature of lung tumors driven by KrasG12D and BrafV600E oncogenes from malignant adenocarcinomas to benign oncocytomas”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
Preferential conversion of glucose into lactate has been demonstrated in genetically normal proliferating cells and virus-infected cells.
“preferential conversion of glucose into lactate has been later demonstrated in genetically normal proliferating cells, as well as in cells infected by viruses”
Quote in the paperSubstantial claim0 of 3 sources checked - Interpretationreasoning
Multiple growth signaling nodes aberrantly activated in cancer share the ability to facilitate cellular access to glucose.
“Taken together, multiple growth signaling nodes that become aberrantly activated in cancer share an ability to facilitate cellular access to glucose, a principal metabolic substrate.”
Quote in the paperSubstantial claim - Premisecitation
The carbon economy of a proliferating cell differs dramatically from that of a quiescent cell.
“The carbon economy of a proliferating cell differs dramatically from that of a cell that is quiescent”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Vander Heiden et al., 2009 source
Not checked in the free run.
- Premisecitation
Cancer cells in vivo often encounter nutrient scarcity due to increased nutrient consumption and inadequate tumor vascular supply.
“cancer cells in vivo often encounter conditions of nutrient scarcity as a result of the increased rates of nutrient consumption and the inadequacies of the tumor vascular supply”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Vaupel et al., 1989
Not checked in the free run.
- Premisecitation
Deletion of Rb family proteins upregulates glutamine uptake and utilization via E2F-dependent upregulation of ASCT2 and GLS1.
“The deletion of Rb family proteins has been shown to upregulate the uptake and utilization of glutamine via the E2F-dependent upregulation of ASCT2 and GLS1”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Reynolds et al., 2014 source
Not checked in the free run.
- Premisecitation
Elevated expression of LPL and MAGL across diverse cancer subtypes correlates with invasiveness.
“An elevated expression of lipoprotein lipase (LPL) and monoacylglycerol lipase (MAGL) across diverse cancer subtypes and correlates with invasiveness”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Supplementation with physiological levels (20-30 mg/mL) of serum albumin enables proliferation of KRASG12D-transformed MEFs in the absence of leucine.
“supplementation of culture medium with physiological levels (20–30 mg/mL) of serum albumin enables proliferation of KRASG12D-transformed MEFs in the absence of an essential amino acid leucine”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Palm et al., 2015 source
Not checked in the free run.
- Interpretationreasoning
Tumor cells utilize opportunistic modes of nutrient acquisition to survive and proliferate in metabolically unfavorable conditions.
“Taken together, tumor cells utilize opportunistic modes of nutrient acquisition, which allow them to survive and proliferate in metabolically unfavorable conditions.”
Quote in the paperSubstantial claim - Premisereasoning
Genetic alterations targeting PI3K, PTEN, INPP4B, and activating RTK mutations or amplifications result in constitutive glucose uptake and metabolism in diverse cancers.
“genetic alterations that target PI-3 kinase, its negative regulators PTEN and INPP4B, as well as activating mutations and gene amplifications in a variety of upstream receptor tyrosine kinases, result in constitutive glucose uptake and metabolism in diverse cancer types.”
Quote in the paperSubstantial claim - Premisecitation
c-myc is a principal driver of glutamine utilization by proliferating cells.
“The transcription factor c-myc, which is upregulated in proliferating cells and is frequently targeted by amplification in various tumor types, is a principal driver of glutamine utilization by proliferating cells”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Wang et al., 2011b
Not checked in the free run.
- cites Wise et al., 2008 source
Not checked in the free run.
- Interpretationnone given
Autophagy cannot supply new biomass and thus cannot support proliferation in nutrient-poor conditions.
“However, autophagy cannot supply cells with new biomass and thus cannot support proliferation in nutrient-poor conditions.”
Quote in the paperNot a substantial claim - Premisecitation
PI3K/Akt signaling acts as a master regulator of glucose uptake.
“PI3K/Akt signaling acts as a master regulator of glucose uptake.”
Quote in the paperSubstantial claim - Premisecitation
Glutamine uptake is negatively regulated by the Rb tumor suppressor family.
“glutamine uptake is also subject to negative regulation by the Rb tumor suppressor family of proteins.”
Quote in the paperNot a substantial claim - Premisecitation
Cancer cells can withstand long periods of nutrient deprivation via macroautophagy.
“cancer cells can withstand long periods of nutrient deprivation via the self-catabolic process of macroautophagy”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Boya et al., 2013 source
Not checked in the free run.
- Premisecitation
Capture of extracellular macromolecules occurs through macropinocytosis, in which bulk extracellular fluid is taken up into giant vesicles.
“capture of extracellular macromolecules occurs through macropinocytosis, a process in which bulk extracellular fluid is taken up into giant vesicles”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Kerr and Teasdale, 2009
Not checked in the free run.
- Premisereasoning
Hypoxia compromises SCD1-catalyzed introduction of double bonds into de novo fatty acids, creating a deficit of unsaturated fatty acids.
“hypoxia compromises stearoyl-CoA desaturase 1 (SCD1)-catalyzed introduction of double bonds into the de novo produced fatty acids, creating a deficit of unsaturated fatty acid species.”
Quote in the paperSubstantial claim - Premisecitation
Cells with mutant KRAS are more likely to perpetrate entosis than to be consumed.
“cells that harbor a mutant KRAS allele are more likely to perpetrate entosis than to be consumed in this process”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Sun et al., 2014 source
Not checked in the free run.
- Premisecitation
Autophagy allows nutrient- or growth factor-deprived cells to maintain viability in culture for weeks.
“autophagy allows nutrient- or growth factor-deprived cells to maintain their viability in culture for weeks”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Lum et al., 2005 source
Not checked in the free run.
- Premisecitation
Hypoxic cells import ready-made unsaturated fatty acids from the environment as lysophospholipids.
“hypoxic cells import “ready-made” unsaturated fatty acids from the surrounding environment in a form of single acyl chain-containing lysophospholipids”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Kamphorst et al., 2013 source
Not checked in the free run.
- Premisenone given
Serine's γ-carbon is transferred to THF by SHMT2 in mitochondria and SHMT1 in cytosol, generating 5,10-methylene-THF and glycine.
“its γ-carbon can be transferred to a carrier molecule, tetrahydrofolate (THF), in a reaction catalyzed by serine hydroxylmethyltransferase 2 (SHMT2) in the mitochondria, and SHMT1 in the cytosol, generating 5, 10-methylene-THF and glycine.”
Quote in the paperSubstantial claim - Interpretationreasoning
Dichotomy in carbon utilization for biosynthetic versus bioenergetic purposes may explain why tumors retain oxidative phosphorylation capacity despite Warburg hypothesis.
“Such apparent dichotomy in utilization of carbon for either predominantly biosynthetic or predominantly bioenergetic purposes may explain why tumors retain the capacity for oxidative phosphorylation, despite the original hypothesis put forth by Otto Warburg.”
Quote in the paperSubstantial claim - Interpretationnone given
Proliferating cells often accumulate electron transport flux exceeding ATP synthase capacity, resulting in excess ROS.
“Even with these adaptations, proliferating cells often accumulate electron transport flux that exceeds the capacity of the ATP synthase, resulting in the formation of excess reactive oxygen species (ROS).”
Quote in the paperSubstantial claim - Premisecitation
OIS triggered by mutant BRAF or RAS alleles is associated with profound oxidative damage and irreversible growth arrest.
“Triggered by the introduction of a mutant BRAF or RAS alleles, OIS is associated with a profound oxidative damage and irreversible growth arrest (Courtois-Cox et al., 2008).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Courtois-Cox et al., 2008 source
Not checked in the free run.
- Premisenone given
3-phosphoglycerate is used as a precursor for biosynthesis of serine, glycine, methyl donor groups, and NADPH.
“the use of 3-phosphoglycerate as a precursor for the biosynthesis of serine, glycine, and as a means to generate methyl donor groups and NADPH.”
Quote in the paperSubstantial claim - Premisenone given
Serine is a major substrate for the one-carbon/folate cycle.
“Serine has a unique metabolic role in the cell as a major substrate for the so-called one-carbon, or folate cycle.”
Quote in the paperSubstantial claim - Interpretationnone given
Emerging evidence favors the hypothesis that glycolysis is used by proliferating cells as a versatile production line generating metabolic intermediates for numerous biosynthetic processes.
“The emerging evidence favors the hypothesis that glycolysis is utilized by proliferating cells as a versatile production line that generates metabolic intermediates for numerous biosynthetic processes.”
Quote in the paperSubstantial claim - Premisenone given
Pentose phosphate pathway utilization is frequently elevated in tumorigenesis.
“Utilization of PPP is frequently elevated in tumorigenesis.”
Quote in the paperSubstantial claim - Premisecitation
PKM2 activity is highly regulated, unlike PKM1.
“Unlike PKM1, PKM2’s activity is highly regulated.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Chaneton et al., 2012; Christofk et al., 2008b; Ye et al., 2012
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Akt activates ACLY, which cleaves TCA-derived citrate into acetyl-CoA and oxaloacetate.
“To this end, Akt activates the ATP-citrate lyase (ACLY) enzyme, which catalyzes cytosol-localized cleavage of the TCA cycle-derived citrate into acetyl-CoA and oxaloacetate (Bauer et al., 2005; Berwick et al., 2002).”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
Stepwise oxidation of one-carbon-THF species produces up to 50% of all cellular NADPH.
“stepwise oxidation of one-carbon-THF species was recently shown to produce up to 50% of all cellular NADPH”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Fan et al., 2014 source
Not checked in the free run.
- Premisecitation
c-myc coordinately increases expression of PDK1, LDH-A, and MCT1.
“For instance, c-myc coordinately increases the expression of PDK1, lactate dehydrogenase A (LDH-A), an enzyme which catalyzes the reductive conversion of pyruvate to lactate, and monocarboxylate transporter (MCT1), which facilitates the efflux of lactate into the extracellular space (Wahlstrom and Arsenian Henriksson, 2015).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Wahlstrom and Arsenian Henriksson, 2015
Not checked in the free run.
- Interpretationreasoning
To balance biosynthetic outputs of glycolysis with pyruvate for TCA cycle activity, proliferating cells evolved a mechanism regulating the last step of glycolysis.
“To balance biosynthetic outputs of glycolysis with its role in providing pyruvate that supports TCA cycle activity, proliferating cells have evolved a novel mechanism by which to regulate the last step of glycolysis.”
Quote in the paperSubstantial claim - Interpretationcitation
Alterations in the one-carbon pathway may be universally selected for in tumorigenesis.
“suggesting that alterations in the one-carbon pathway may be universally selected for in tumorigenesis”
Quote in the paperSubstantial claim - Interpretationreasoning
Damaging consequences of ROS overproduction from overloaded ETC may underlie oncogene-induced cellular senescence (OIS).
“In fact, the damaging consequences of the overproduction of ROS from the overloaded electron transport chain may underlie the phenomenon of oncogene-induced cellular senescence (OIS).”
Quote in the paperNot a substantial claim - Premisenone given
Fructose-6-phosphate can leave glycolysis and become a substrate for hexosamine biosynthesis.
“Fructose-6-phosphate, which follows glucose-6-phosphate in the glycolytic pathway, can also leave glycolysis and become utilized as a substrate for hexosamine biosynthesis.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Growth factor-dependent signaling inhibits PKM2, causing glycolytic intermediates to accumulate until the cell's need for free serine is saturated.
“In such a manner, growth factor-dependent signal transduction inhibits PKM2, leading to accumulation of glycolytic intermediates until the growing cell’s need for a catabolizable pool of free serine is saturated.”
Quote in the paperSubstantial claim - Premisecitation
HIF1α stabilization by hypoxia or oncogenic contexts triggers coordinated transcriptional upregulation of LDH-A and PDK1.
“Finally, stabilization of HIF1α by hypoxia or in various oncogenic contexts also triggers coordinated transcriptional upregulation of LDH-A and PDK1 (Kim et al., 2006; Papandreou et al., 2006).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Attenuation of PDH activity via ectopic PDK1 expression or RNAi depletion of PDP2 bypasses mutant BRAFV600E-induced OIS and potentiates tumorigenesis.
“Interestingly, attenuation of the activity of pyruvate dehydrogenase (PDH), a gatekeeper enzyme that converts pyruvate into acetyl-CoA, via the ectopic expression of its negative regulator pyruvate dehydrogenase kinase 1 (PDK1) or an RNAi-mediated depletion of a PDH phosphatase PDP2 was found to bypass mutant BRAFV600E-induced OIS and potentiate tumorigenesis (Kaplon et al., 2013).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Kaplon et al., 2013 source
Not checked in the free run.
- Premisereasoning
Oxaloacetate is converted to malate and re-imported into mitochondria to maintain anaplerosis.
“Oxaloacetate is converted to malate and re-imported into mitochondria to maintain anaplerosis”
Quote in the paperSubstantial claim - Premisecitation
TCF/β-catenin signaling upregulates MCT1 and PDK1 transcription.
“In addition to c-myc, TCF/β-catenin signaling has also been shown to upregulate MCT1 and PDK1 transcription (Pate et al., 2014).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Pate et al., 2014 source
Not checked in the free run.
- Premisecitation
PKM2 can be allosterically activated by excess accumulation of other glucose metabolism byproducts including SAICAR, an intermediate of ribose-5-phosphate biosynthesis.
“In addition to serine, PKM2 can also be allosterically activated by excess accumulation of other byproducts of glucose metabolism including succinylaminoimidazolecarboxamide (SAICAR), an intermediate product of ribose-5-phosphate biosynthesis (Keller et al., 2012).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Keller et al., 2012 source
Not checked in the free run.
- Premisecitation
Increased GPDH activity has been detected in prostate cancer cells, insulinomas, and carcinoid tumors.
“In fact, increased activity of GPDH has been detected in prostate cancer cells, insulinomas and carcinoid tumors (Chowdhury et al., 2005; MacDonald et al., 1990).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Chowdhury et al., 2005 source
Not checked in the free run.
- cites MacDonald et al., 1990
Not checked in the free run.
- Premisecitation
MTHFD2 is among the top three most frequently overexpressed metabolic enzymes in cancer.
“methylene tetrahydrofolate dehydrogenase 2 (MTHFD2), a component of the mitochondrial arm of the one-carbon pathway, was found to be among the top three most frequently overexpressed metabolic enzymes in cancer”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Nilsson et al., 2014 source
Not checked in the free run.
- Interpretationcitation
A variety of oncogenes contribute to the metabolic adaptations of proliferating cells outlined above.
“A variety of oncogenes have been shown to contribute to the metabolic adaptations of proliferating cells outlined above.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Growth factor signaling promotes use of select TCA cycle intermediates for generating biosynthetic precursors.
“In addition to glycolytic intermediates, growth factor signaling promotes the use of select TCA cycle intermediates in the generation of biosynthetic precursors as well.”
Quote in the paperSubstantial claim - Premisenone given
One-carbon-THF species are used for biosynthesis of purines, thymidine, and S-adenosylmethionine.
“One-carbon-THF species are utilized as substrates for the biosynthesis of purines, thymidine, as well as in the production of S-adenosylmethionine, a principal substrate for cellular methylation reactions.”
Quote in the paperNot a substantial claim - Premisecitation
Hypoxia-driven induction of SHMT2 protects cells from hypoxia-associated oxidative stress.
“hypoxia-driven induction of SHMT2 expression was shown to protect cells from hypoxia-associated oxidative stress”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ye et al., 2014
Not checked in the free run.
- Premisereasoning
Excess NADH from glycolysis is not imported into mitochondria solely through chemical shuttles but also used to convert DHAP into glycerol-3-phosphate that donates electrons directly into ETC via mGPDH on outer mitochondrial membrane.
“Excess NADH generated by glycolysis is not imported into mitochondria of proliferating cells solely through chemical shuttles but is also utilized to convert the glycolytic intermediate DHAP into glycerol-3-phosphate that donates electrons directly into the electron transport chain utilizing glycerol-3-phosphate dehydrogenase (mGPDH) localized to the outer mitochondrial membrane.”
Quote in the paperSubstantial claim - Premisecitation
Cancer cells may utilize as much as 50% of glucose-derived carbon in serine biosynthesis and subsequent catabolism.
“cancer cells may utilize as much as 50% of glucose-derived carbon in serine biosynthesis and its subsequent catabolism”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Locasale et al., 2011 source
Not checked in the free run.
- Premisecitation
Moderate ROS generated during respiration or by NADPH oxidases constitute signaling input contributing to maintenance of tumorigenic state.
“Whereas overproduction of ROS is detrimental to cell growth and survival, moderate levels of ROS, which are generated either during respiration or in a targeted manner by a class of NADPH oxidases, constitute an important signaling input that contributes to the maintenance of the tumorigenic state (Sullivan and Chandel, 2014).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Sullivan and Chandel, 2014
Not checked in the free run.
- Interpretationreasoning
Mitochondria are protected from excess glycolysis because pyruvate entering TCA cycle is channeled into citrate secreted into cytosol via mitochondrial tricarboxylate carrier and broken into acetyl-CoA and oxaloacetate.
“Mitochondria are protected further from excess glycolysis because any pyruvate that does enter the TCA cycle is channeled into citrate that is secreted into the cytosol through the mitochondrial tricarboxylate carrier and broken down into acetyl-CoA and oxaloacetate.”
Quote in the paperSubstantial claim - Premisecitation
PI3K/Akt activation allows a cell to expand its cytosolic acetyl-CoA pool, a substrate for de novo fatty acid biosynthesis.
“In particular, PI3K/Akt activation allows a cell to expand its cytosolic pool of acetyl-CoA, a substrate for the de novo biosynthesis of fatty acids.”
Quote in the paperSubstantial claim0 of 2 sources checked - Interpretationreasoning
Electrons entering mitochondrial ETC through glycerol phosphate dehydrogenase and Complex I from mitochondrial conversion of malate to oxaloacetate are sufficient to maintain mitochondrial integrity and ATP production despite reduced catabolic TCA cycle activity.
“The electrons entering the mitochondrial electron transport chain through glycerol phosphate dehydrogenase activity and Complex I as a result of mitochondrial conversion of malate to oxaloacetate are sufficient to maintain both mitochondrial integrity and ATP production despite reduced catabolic TCA cycle activity.”
Quote in the paperNot a substantial claim - Premisenone given
Biosynthesis of asparagine from aspartate, catalyzed by ASNS, utilizes amide nitrogen of glutamine.
“In contrast, biosynthesis of asparagine from aspartate, catalyzed by asparagine synthetase (ASNS), utilizes the amide nitrogen of glutamine.”
Quote in the paperNot a substantial claim - Premisecitation
Glutamine synthetase is overexpressed in some cancers.
“Glutamine synthetase (GS) has been found to be overexpressed in some cancers (Osada et al., 2000);”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Osada et al., 2000 source
Not checked in the free run.
- Premisereasoning
Assembly of pyrimidine and purine rings utilizes aspartate derived from transamination of oxaloacetate and glutamic acid, both catabolites of glutamine.
“In addition, the assembly of both pyrimidine and purine rings utilizes aspartate, which is derived from the transamination of the TCA cycle metabolite oxaloacetate and glutamic acid, both of which are catabolites of glutamine.”
Quote in the paperSubstantial claim - Premisecitation
Mutant p53 alleles facilitate expression of nucleotide biosynthesis genes including IMPDH1/2, GMPS, DCK, and TK1.
“Besides the regulatory inputs from c-myc, mutant p53 alleles have also been shown to facilitate expression of nucleotide biosynthesis genes, among which are IMPDH1 and 2, GMP synthetase (GMPS) and nucleoside salvage enzymes deoxycytidine kinase (DCK) and thymidine kinase (TK1) (Kollareddy et al., 2015).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Kollareddy et al., 2015 source
Not checked in the free run.
- Interpretationreasoning
To maintain ability to synthesize non-essential amino acids, their production must be balanced with anaplerotic influx into TCA cycle.
“To maintain the ability to synthesize these amino acids, their production must be carefully balanced with an anaplerotic influx into the cycle.”
Quote in the paperSubstantial claim - Premisecitation
Asparagine plays a crucial regulatory role in conditions of glutamine deprivation.
“Yet despite this, asparagine plays a crucial regulatory role in conditions of glutamine deprivation (Zhang et al., 2014).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Zhang et al., 2014 source
Not checked in the free run.
- Premisereasoning
Proliferating cells must synthesize nitrogen-containing molecules de novo, including nucleotides, non-essential amino acids, and polyamines.
“Indeed, a proliferating cell must synthesize a number of nitrogen-containing molecules de novo, including nucleotides, non-essential amino acids and polyamines.”
Quote in the paperSubstantial claim - Premisecitation
c-myc-regulated targets include PRPS2 and CAD.
“Among the c-myc-regulated targets are phosphoribosyl pyrophosphate synthetase 2 (PRPS2), which catalyzes a first step of purine biosynthesis, as well as carbamoyl phosphate synthetase II (CAD), which initiates the pyrimidine ring-building cascade (Cunningham et al., 2014; Eberhardy and Farnham, 2001; Mannava et al., 2008).”
Quote in the paperNot a substantial claim0 of 3 sources checked - Premisenone given
Anaplerotic entry of glucose-derived carbons into TCA cycle occurs via carboxylation of pyruvate to oxaloacetate catalyzed by PC.
“Anaplerotic entry of glucose-derived carbons into the TCA cycle takes place via carboxylation of pyruvate into the TCA cycle intermediate oxaloacetate, catalyzed by pyruvate carboxylase (PC).”
Quote in the paperSubstantial claim - Premisecitation
c-myc orchestrates nucleotide biosynthesis by upregulating expression of nucleotide biosynthesis enzymes.
“The oncogene c-myc orchestrates nucleotide biosynthesis by upregulating the expression of a number of nucleotide biosynthesis enzymes.”
Quote in the paperNot a substantial claim - Premisecitation
Similar accumulation of glucose-derived glutamine within tumor tissue was observed in a mouse model of c-Met-driven liver cancer.
“furthermore, a similar accumulation of glucose-derived glutamine within the tumor tissue was observed in a mouse model of c-Met-driven liver cancer (Yuneva et al., 2012).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Yuneva et al., 2012 source
Not checked in the free run.
- Premisereasoning
Arginine becomes conditionally essential in some tumorigenic contexts.
“Arginine, despite being a non-essential amino acid, also becomes conditionally essential in some tumorigenic contexts (Figure 5).”
Quote in the paperSubstantial claim - Premisenone given
Oxidation of glutamine-derived α-ketoglutarate into oxaloacetate helps maintain ability of cells to synthesize citrate.
“Oxidation of glutamine-derived α-ketoglutarate into oxaloacetate not only helps to maintain the ability of cells to synthesize citrate.”
Quote in the paperSubstantial claim - Premisenone given
Acute lymphoblastic leukemia cells lack ASNS expression, leading to asparagine auxotrophy.
“In contrast, acute lymphoblastic leukemia cells lack ASNS expression, leading to asparagine auxotrophy.”
Quote in the paperNot a substantial claim - Premisenone given
Transcriptional effects of c-myc and E2F result in enhanced cellular uptake of glutamine.
“As discussed above, the transcriptional effects of c-myc and E2F result in enhanced cellular uptake of glutamine.”
Quote in the paperNot a substantial claim - Premisenone given
Asparagine is the only amino acid that mammalian cells do not catabolize.
“Though structurally similar to glutamine, asparagine is the only amino acid that mammalian cells do not catabolize.”
Quote in the paperNot a substantial claim - Premisecitation
Tracing glucose-derived carbons in human patients and mouse models of glioblastoma and NSCLC reveals that in these contexts the principal source for TCA cycle intermediates is glucose, not glutamine.
“In fact, tracing the fate of glucose-derived carbons in human patients and in mouse models of glioblastoma and non-small cell lung carcinoma (NSCLC) reveals that at least in these tumorigenic contexts, the principal source for the TCA cycle intermediates is not glutamine, but glucose (Maher et al., 2012; Marin-Valencia et al., 2012; Sellers et al., 2015).”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisenone given
Major anaplerotic substrate in growing cells is glutamine.
“The major anaplerotic substrate in growing cells is glutamine.”
Quote in the paperSubstantial claim - Premisecitation
Glutamine deprivation leads to S-phase cell cycle arrest in certain cellular contexts.
“Accordingly, glutamine levels have been shown to be rate-limiting for cell cycle progression, and glutamine deprivation leads to cell cycle arrest in the S-phase in certain cellular contexts (Fontenelle and Henderson, 1969; Gaglio et al., 2009).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Fontenelle and Henderson, 1969
Not checked in the free run.
- cites Gaglio et al., 2009 source
Not checked in the free run.
- Premisenone given
Majority of proliferating cells in culture require exogenous glutamine.
“Despite the existence of a glutamine biosynthetic pathway in mammalian cells, the majority of proliferating cells in culture require an exogenous supply of glutamine.”
Quote in the paperSubstantial claim - Premisecitation
Brain tumor types including primary glioblastomas and brain metastases assimilate exogenous acetate and incorporate acetate-derived carbons into de novo synthesized fatty acids.
“Specifically, a variety of tumor types localized to the brain, including primary glioblastomas as well as brain metastases that originated from other tissues, have been shown to assimilate exogenous acetate and incorporate acetate-derived carbons into de novo synthesized fatty acids (Comerford et al., 2014; Mashimo et al., 2014; Schug et al., 2015).”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
Glutamine levels are rate-limiting for cell cycle progression.
“Accordingly, glutamine levels have been shown to be rate-limiting for cell cycle progression, and glutamine deprivation leads to cell cycle arrest in the S-phase in certain cellular contexts (Fontenelle and Henderson, 1969; Gaglio et al., 2009).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Fontenelle and Henderson, 1969
Not checked in the free run.
- cites Gaglio et al., 2009 source
Not checked in the free run.
- Premisenone given
Amide group of glutamine is indispensable donor of nitrogen for purine and pyrimidine biosynthesis.
“The amide group of glutamine is an indispensable donor of nitrogen for the biosynthesis of purine and pyrimidine bases (Figure 5).”
Quote in the paperSubstantial claim - Premisecitation
Some cell types, such as embryonic stem cells and luminal breast cancer cells, can proliferate without glutamine in culture medium, indicating de novo glutamine production in some contexts.
“Interestingly, some cell types, such as embryonic stem cells and luminal breast cancer cells, are capable of proliferating in the absence of glutamine in the culture medium, indicating that in some cellular contexts, glutamine can be produced de novo (Carey et al., 2015; Kung et al., 2011).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
De novo cholesterol biosynthesis from malonyl-CoA plays a role in tumorigenesis.
“In addition to fatty acid production, the de novo biosynthesis of cholesterol from malonyl-CoA plays a role in tumorigenesis as well.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Freed-Pastor et al., 2012 source
Not checked in the free run.
- Premisecitation
Aspartate biosynthesis is critically dependent on a cell's ability to conduct oxidative phosphorylation.
“In fact, aspartate biosynthesis has recently been shown to be critically dependent upon a cell’s ability to conduct oxidative phosphorylation (Birsoy et al., 2015; Sullivan et al., 2015).”
Quote in the paperSubstantial claim0 of 2 sources checked - Interpretationreasoning
Upregulation of ACSS2 may allow cells to recycle acetate released from deacetylation of histones and other cellular proteins.
“Furthermore, upregulation of ACSS2 may potentially allow cells to recycle acetate released from deacetylation of histones and other cellular proteins as well.”
Quote in the paperNot a substantial claim - Premisecitation
Extracellular acetate is utilized by some cancers as source of acetyl-CoA for biosynthesis.
“Finally, extracellular acetate has recently been shown to be utilized by some cancers as a source of acetyl-CoA for biosynthesis.”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisenone given
TCA cycle provides metabolic precursors for biosynthesis of non-essential amino acids including aspartate and asparagine.
“In addition to supplying citrate, the TCA cycle also provides metabolic precursors for the biosynthesis of non-essential amino acids including aspartate and asparagine.”
Quote in the paperSubstantial claim - Premisecitation
Depletion of plasma asparagine by recombinant bacterial L-Asparaginase is effective anticancer intervention for acute lymphoblastic leukemia.
“Depletion of plasma asparagine by a recombinant form of bacterial L-Asparaginase is an effective anticancer intervention for this cancer type (Hill et al., 1967; Pieters et al., 2011).”
Quote in the paperSubstantial claim0 of 2 sources checked - Interpretationcitation
α-ketoglutarate may provide citrate for de novo lipogenesis when hypoxia or oncogenic contexts create deficit of glucose-derived acetyl-CoA.
“Finally, α-ketoglutarate may provide a source of citrate for the de novo lipogenesis in a setting in which hypoxia or certain oncogenic contexts create a deficit of glucose-derived acetyl-CoA.”
Quote in the paperNot a substantial claim - Premisenone given
Glutamine-derived glutamate serves as nitrogen donor for production of non-essential amino acids via transamination.
“Glutamine-derived glutamate serves as a donor of nitrogen for the production of a number of non-essential amino acids via transamination.”
Quote in the paperNot a substantial claim - Premisecitation
Other c-myc targets involved in nucleotide biosynthesis are TS, IMPDH1, and IMPDH2.
“Other targets of c-myc that are involved in nucleotide biosynthesis are thymidylate synthase (TS) and inosine monophosphate dehydrogenase 1 (IMPDH1) and 2 (IMPDH2) (Liu et al., 2008; Mannava et al., 2008).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Interpretationreasoning
Growth signaling elevates cellular demand for reduced nitrogen.
“In addition to increasing the consumption of carbon in biosynthetic pathways, growth signaling concomitantly elevates the cellular demand for reduced nitrogen.”
Quote in the paperSubstantial claim - Premisecitation
Most proliferating cells depend on continuous glutamine supply to maintain integrity of TCA cycle intermediates.
“Most proliferating cells depend on a continuous supply of glutamine to maintain the integrity of TCA cycle intermediates (DeBerardinis et al., 2007).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites DeBerardinis et al., 2007 source
Not checked in the free run.
- Premisecitation
Human glioblastoma samples implanted into immunocompromised mouse brains accumulate glutamine relative to normal brain tissue.
“In addition, human glioblastoma samples implanted directly into the brains of immunocompromised mice were found to accumulate glutamine relative to the normal brain tissue (Marin-Valencia et al., 2012);”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Marin-Valencia et al., 2012 source
Not checked in the free run.
- Interpretationreasoning
Glutamine is a key structural building block in nucleotide biosynthesis.
“Thus, glutamine is a key structural building block in the biosynthesis of nucleotides.”
Quote in the paperSubstantial claim - Premisecitation
Histone and DNA methylation is sensitive to alterations in SAM levels.
“A number of recent reports demonstrate that histone and DNA methylation is sensitive to alterations in SAM levels (Chiang et al., 2009; Shyh-Chang et al., 2013; Towbin et al., 2012).”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
p300 histone acetyltransferase utilizes crotonyl-CoA as substrate.
“In addition to acetyl-CoA, a p300 histone acetyltransferase has recently been shown to utilize crotonyl-CoA as a substrate as well.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Sabari et al., 2015 source
Not checked in the free run.
- Premisecitation
Meta-analysis identified PYCR1 as one of the most commonly overexpressed genes in tumors.
“In fact, a meta-analysis of metabolic enzyme expression across diverse tumor types identified PYCR1 as one of the most commonly overexpressed genes in tumors (Nilsson et al., 2014).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Nilsson et al., 2014 source
Not checked in the free run.
- Premisecitation
2-HG acts as competitive inhibitor of α-ketoglutarate-dependent dioxygenases due to structural similarity to α-ketoglutarate.
“Owing to its structural similarity to α-ketoglutarate, 2-HG acts as a competitive inhibitor of α-ketoglutarate-dependent dioxygenases (Xu et al., 2011).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Xu et al., 2011
Not checked in the free run.
- Premisecitation
Reduced expression of ASS1 and ASL is associated with poor prognosis and resistance to chemotherapy.
“Reduced expression of ASS1 and ASL are associated with poor prognosis and resistance to chemotherapy (McAlpine et al., 2014; Nicholson et al., 2009).”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
IDH1 and IDH2 mutations identified in low-grade glioma, chondrosarcoma, cholangiocarcinoma, and AML.
“IDH1 and IDH2 mutations have been identified in low-grade glioma, where they represent a likely initiator lesion, as well as in chondrosarcoma, cholangiocarcinoma, and acute myeloid leukemia (AML) (Balss et al., 2008; Borger et al., 2012; Cohen et al., 2013; Mardis et al., 2009; Parsons et al., 2008; Paschka et al., 2010).”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisereasoning
Activated Akt expands extramitochondrial acetyl-CoA pool by activating ACLY.
“Activated Akt expands the extramitochondrial pool of acetyl-CoA by activating ACLY, which converts cytosolic citrate into acetyl-CoA and oxaloacetate.”
Quote in the paperSubstantial claim - Premisenone given
Cytosolic acetyl-CoA builds up when cells metabolize more glucose than needed for bioenergetic support.
“A key metabolite that builds up when cells metabolize more glucose than needed for bioenergetic support is cytosolic acetyl-CoA.”
Quote in the paperSubstantial claim - Premisereasoning
α-ketoglutarate-dependent dioxygenases are prone to inhibition by succinate and fumarate.
“In addition, α-ketoglutarate-dependent dioxygenases are prone to the inhibition by their reaction product, succinate, as well as by fumarate, the downstream product of succinate degradation in the TCA cycle.”
Quote in the paperSubstantial claim - Premisecitation
Glucose- and oncogene-driven increases in global histone acetylation are blocked by ACLY inhibition.
“Furthermore, studies have shown that both the glucose- and oncogene-driven increases in global histone acetylation are blocked by ACLY inhibition (Lee et al., 2014; Wellen et al., 2009).”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
Deposition of crotonyl marks on select histone tail residues activates gene expression more potently than acetyl marks.
“Notably, deposition of crotonyl marks on select amino acid residues within histone tails was found to activate gene expression even more potently than acetyl marks (Sabari et al., 2015).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Sabari et al., 2015 source
Not checked in the free run.
- Premisecitation
Mutant IDH1 and IDH2 exhibit neomorphic function converting α-ketoglutarate to D-2-hydroxyglutarate.
“In contrast to wild-type isocitrate dehydrogenases, which convert the TCA cycle metabolite isocitrate to α-ketoglutarate, a mutant form of IDH prefers to use α-ketoglutarate as a substrate, catalyzing its conversion to the D-enantiomer of 2-hydroxyglutarate (2-HG) (Dang et al., 2010; Ward et al., 2010).”
Quote in the paperSubstantial claim0 of 2 sources checked - Interpretationreasoning
Another possible reason for arginine auxotrophy in cancer may be that suppression of ASS1-driven argininosuccinate production leads to aspartate accumulation for nucleotide biosynthesis.
“Another possible reason for arginine auxotrophy in cancer may be related to the fact that the suppression of ASS1-driven argininosuccinate production leads to an accumulation of its substrate aspartate, which can then be applied toward nucleotide biosynthesis.”
Quote in the paperNot a substantial claim - Premisenone given
Wide variety of post-translational modifications are carried out by α-ketoglutarate-dependent dioxygenases.
“A wide variety of post-translational modifications in the cell are carried out by the members of a large class of α-ketoglutarate-dependent dioxygenases.”
Quote in the paperNot a substantial claim - Premisenone given
Cytosolic acetyl-CoA is obligate substrate for enzymes that acetylate histones and other proteins.
“Cytosolic acetyl-CoA is the obligate substrate for enzymes that acetylate histones and other proteins.”
Quote in the paperSubstantial claim - Premisenone given
Crotonyl-CoA can be produced from catabolism of lysine, tryptophan, and butyrate.
“Crotonyl-CoA can be produced from the catabolism of lysine and tryptophan, as well as of a short-chain fatty acid butyrate.”
Quote in the paperNot a substantial claim - Interpretationcitation
Metabolic networks are not merely passive recipients of growth signals but directly transmit information about cellular metabolic state to regulatory enzymes including those mediating epigenetic marks.
“However, metabolic networks themselves are not merely passive recipients of growth signals, but quite the contrary, directly transmit the information about the cellular metabolic state to a diverse array of regulatory enzymes, among which are those that mediate the deposition and removal of epigenetic marks from chromatin (Katada et al., 2012)(Figure 6).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Katada et al., 2012 source
Not checked in the free run.
- Interpretationreasoning
Gain-of-function mutations of IDH1 and IDH2 modulate activity of α-ketoglutarate-dependent dioxygenases.
“Another prominent class of tumor-associated genetic alterations that modulate the activity of α-ketoglutarate-dependent dioxygenases are gain-of-function mutations of isocitrate dehydrogenase 1 (IDH1) and isocitrate dehydrogenase 2 (IDH2).”
Quote in the paperSubstantial claim - Premisecitation
IDH-driven gliomas, leukemias, and chondrosarcomas display prominent CpG island hypermethylation reminiscent of SDH- and FH-deficient cancers.
“Indeed, IDH-driven gliomas, leukemias and chondrosarcomas display a prominent CpG island hypermethylation, reminiscent of the hypermethylator phenotype seen in SDH- and FH-deficient cancers (Figueroa et al., 2010; Lu et al., 2013; Turcan et al., 2012).”
Quote in the paperSubstantial claim0 of 3 sources checked - Interpretationreasoning
Similarly to carbon, nitrogen metabolism undergoes complex reprogramming in tumorigenesis.
“Taken together, while this area of cancer metabolism remains under active investigation, it is clear that similarly to carbon, the metabolism of nitrogen undergoes complex reprogramming in tumorigenesis.”
Quote in the paperSubstantial claim - Premisenone given
Numerous methylation reactions including histone, DNA, and mRNA methylation utilize SAM as methyl donor.
“Numerous methylation reactions in the cell, including the deposition of methyl marks on histone tails, cytosine methylation on DNA and adenosine methylation on mRNA utilize S-adenosylmethionine (SAM) as a donor of methyl groups.”
Quote in the paperNot a substantial claim - Premisecitation
POX expression inhibits tumor cell growth by triggering G2 cell cycle arrest.
“Expression of POX has been shown to inhibit tumor cell growth by triggering cell cycle arrest in the G2 phase (Liu et al., 2009).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Liu et al., 2009 source
Not checked in the free run.
- Premisecitation
Sensitive to NAD+ or FAD availability, these enzymes orchestrate global post-translational and epigenetic changes that promote energy conservation.
“Sensitive to changes in NAD+ or FAD availability, these enzymes orchestrate global post-translational and epigenetic changes that promote energy conservation (Hino et al., 2012; Schwer and Verdin, 2008).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Hino et al., 2012 source
Not checked in the free run.
- cites Schwer and Verdin, 2008
Not checked in the free run.
- Premisecitation
PYCR1 expression is upregulated by c-myc.
“The expression of the principal enzyme in proline biosynthesis, pyrroline-5-carboxylate reductase (PYCR1), is upregulated by c-myc (Liu et al., 2012).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Liu et al., 2012 source
Not checked in the free run.
- Premisenone given
Reaction mechanism of α-ketoglutarate-dependent dioxygenases involves concurrent oxidation of α-ketoglutarate into succinate.
“The reaction mechanism of α-ketoglutarate-dependent dioxygenases involves a concurrent oxidation of a co-substrate α-ketoglutarate into succinate.”
Quote in the paperSubstantial claim - Premisecitation
Arginine auxotrophy of tumors is being exploited in development of anticancer therapies.
“Accordingly, the auxotrophy of tumors for arginine is being exploited in the development of anticancer therapies (Delage et al., 2010).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Delage et al., 2010 source
Not checked in the free run.
- Premisecitation
c-myc-orchestrated remodeling of non-essential amino acid metabolism involves proline metabolism.
“In addition to its effects on glutamine metabolism, c-myc-orchestrated remodeling of non-essential amino acid metabolism involves the metabolism of proline (Phang et al., 2008).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Phang et al., 2008 source
Not checked in the free run.
- Premisecitation
Histone acetylation is exquisitely sensitive to alterations in cellular nutritional and signaling status.
“Histone acetylation is exquisitely sensitive to alterations in the cellular nutritional and signaling status (Cai et al., 2011; Shi and Tu, 2013).”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
Immunohistochemical analysis of glioblastoma and prostate tumor samples shows Akt activation levels closely correlate with global histone acetylation status.
“Immunohistochemical analysis of glioblastoma and prostate tumor samples has shown that Akt activation levels closely correlate with global histone acetylation status (Lee et al., 2014).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Lee et al., 2014 source
Not checked in the free run.
- Premisecitation
Biallelic loss of SDH found in familial paragangliomas and pheochromocytomas and in a subset of sporadic GIST creates succinate build-up.
“For instance, a biallelic loss of succinate dehydrogenase (SDH), an alteration found in familial paragangliomas and pheochromocytomas, as well as in a subset of sporadic gastrointestinal stromal tumors, creates a build-up of succinate (Astuti et al., 2001; Janeway et al., 2011).”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
Large variety of novel histone marks, such as formylation, propionylation, butyrylation, malonylation, and succinylation, have been identified by tandem mass spectrometry.
“In fact, a large variety of novel histone marks, such as formylation, propionylation, butyrylation, malonylation and succinylation have recently been identified by tandem mass spectrometry (Chen et al., 2007; Wisniewski et al., 2008; Xie et al., 2012).”
Quote in the paperNot a substantial claim0 of 3 sources checked - Interpretationnone given
Aberrantly activated growth and survival signals that drive tumorigenesis facilitate reprogramming of cancer cell metabolism to enable increased nutrient acquisition and biosynthesis.
“Aberrantly activated growth and survival signals that drive tumorigenesis facilitate the reprogramming of cancer cell metabolism to enable increased nutrient acquisition and biosynthesis.”
Quote in the paperSubstantial claim - Premisereasoning
Intracellular α-ketoglutarate levels can directly influence activity of α-ketoglutarate-dependent dioxygenases.
“Accordingly, intracellular levels of α-ketoglutarate can directly influence the activity of these enzymes.”
Quote in the paperSubstantial claim - Premisecitation
ASS1 and ASL are frequently epigenetically silenced in melanoma, renal cell carcinoma, and hepatocellular carcinoma.
“Intriguingly, both ASS1 and ASL enzymes are frequently epigenetically silenced in melanoma, renal cell carcinoma and hepatocellular carcinoma (Bowles et al., 2008; Ensor et al., 2002; Yoon et al., 2007).”
Quote in the paperSubstantial claim0 of 3 sources checked - Interpretationcitation
Removal of acetyl and methyl marks is guided by cellular metabolic state.
“The removal of acetyl and methyl marks is also guided by the cellular metabolic state.”
Quote in the paperSubstantial claim - Premisecitation
HIF1α elevation in context of SDH loss can be reversed by addition of membrane-permeable α-ketoglutarate.
“In fact, the latter, at least in the context of SDH loss, can be reversed by the addition of a membrane-permeable form of α-ketoglutarate (MacKenzie et al., 2007).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites MacKenzie et al., 2007 source
Not checked in the free run.
- Premisecitation
High dietary choline intake is linked to a significantly increased risk of lethal prostate cancer.
“High dietary intake of choline has been linked to a significantly increased risk of lethal prostate cancer (Richman et al., 2012).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Richman et al., 2012 source
Not checked in the free run.
- Premisenone given
Lactate secretion through MCT1 is coupled to H+ co-transport, causing acidification of the cellular microenvironment.
“The secretion of lactate into the extracellular space via the monocarboxylate transporter MCT1 is coupled to the co-transport of H+, which causes acidification of the cellular microenvironment.”
Quote in the paperSubstantial claim - Premisecitation
Small molecule inhibition of mutant IDH1 in glioma and IDH2 in leukemia promotes differentiation.
“Conversely, small molecule-mediated inhibition of mutant IDH1 in glioma and IDH2 in leukemia markedly promoted differentiation in these contexts (Rohle et al., 2013; Wang et al., 2013).”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
Cysteine is the second most depleted amino acid in pancreatic tumors compared with normal pancreatic tissue.
“Consistent with its heavy utilization by cancer cells, cysteine was found to be the second most depleted amino acid in pancreatic tumors in comparison to normal pancreatic tissue (Kamphorst et al., 2015).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Kamphorst et al., 2015 source
Not checked in the free run.
- Premisecitation
The xCT transporter exports at least 30% of glutamine taken up by cells as glutamate, exchanging it for cysteine.
“In fact, no less than 30% of imported glutamine was shown to leave the cell through the xCT transporter as glutamate, while being exchanged for cysteine (Collins et al., 1998).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Collins et al., 1998 source
Not checked in the free run.
- Premisecitation
Carbonic anhydrase expression, especially the CAIX isoform, increases during hypoxia.
“Expression of carbonic anhydrases, in particular the CAIX isoform, is elevated during hypoxia (Svastova et al., 2004).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Svastova et al., 2004 source
Not checked in the free run.
- Interpretationreasoning
Conditions in the tumor microenvironment strongly affect cancer cell metabolism.
“Reciprocally, the conditions within the tumor microenvironment have profound effects on the metabolism of a cancer cell.”
Quote in the paperSubstantial claim - Premisecitation
L-2-HG is implicated as metabolic mediator of cellular stress response to hypoxia.
“Furthermore, L-2-HG levels were found to increase in response to hypoxia as a result of promiscuous substrate use by LDH-A and malate dehydrogenase (MDH) (Intlekofer et al., 2015), and two recent studies implicate L-2-HG as a metabolic mediator of the cellular stress response to hypoxia (Intlekofer et al., 2015; Oldham et al., 2015).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
CO2 produced by mitochondrial decarboxylation diffuses out of cells and is converted by extracellular carbonic anhydrases into H+ and HCO3−, contributing to extracellular acidification.
“In addition, the surplus of CO2 generated in mitochondrial decarboxylation reactions contributes to the extracellular acidification as well. To this end, CO2 diffuses into the extracellular space, where it becomes converted to H+ and HCO3− by a class of extracellular carbonic anhydrases (Swietach et al., 2007).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Swietach et al., 2007 source
Not checked in the free run.
- Premisereasoning
High consumption of extracellular glucose and glutamine by cancer cells leads to extracellular lactate accumulation.
“The high utilization of extracellular glucose and glutamine by cancer cells results in the accumulation of extracellular lactate, which was shown to affect a number of cell types within the tumor microenvironment.”
Quote in the paperSubstantial claim - Premisecitation
2-HG abundance has been used for 1H magnetic resonance spectroscopy-based imaging of IDH-mutant gliomas.
“The abundance of 2-HG has been utilized for 1H magnetic resonance spectroscopy-based imaging of IDH-mutant gliomas (Choi et al., 2012).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Choi et al., 2012 source
Not checked in the free run.
- Premisecitation
A diet high in choline and betaine is associated with decreased breast and lung cancer risk.
“In contrast, a diet high in choline and betaine was associated with a decreased breast and lung cancer risk (Xu et al., 2009a; Ying et al., 2013; Zhang et al., 2013).”
Quote in the paperNot a substantial claim0 of 3 sources checked - Premisereasoning
Proliferating cancer cells change the metabolic composition of the extracellular space around them.
“In addition to these inputs, proliferating cancer cells alter the metabolic composition of the extracellular milieu around them as well (Figure 7).”
Quote in the paperSubstantial claim - Premisenone given
Choline and its derivative betaine can serve as methyl-group donors for SAM production.
“Two other dietary compounds that can be utilized as donors of methyl groups for SAM production are choline and its derivative betaine.”
Quote in the paperSubstantial claim - Premisenone given
Small molecule inhibitors of IDH1 and IDH2 have been reported to induce remissions in phase I clinical trials for AML patients with respective mutations.
“Moreover, small molecule inhibitors of IDH1 and IDH2 have been reported to induce remissions in phase I clinical trials for treatment of AML patients with the respective mutations.”
Quote in the paperNot a substantial claim - Premisecitation
Multiple lines of evidence suggest that sulfur metabolism may be reprogrammed in cancer.
“For instance, multiple lines of evidence indicate that the metabolism of sulfur may undergo reprogramming in cancer.”
Quote in the paperNot a substantial claim - Premisecitation
Kynurenine that accumulates can bind the aryl hydrocarbon receptor (AhR) as a ligand.
“Furthermore, accumulated kynurenine acts as a ligand for aryl hydrocarbon receptor (AhR) (Opitz et al., 2011).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Opitz et al., 2011 source
Not checked in the free run.
- Premisecitation
Lactate accumulation promotes angiogenesis.
“Furthermore, lactate accumulation is instrumental for the promotion of angiogenesis.”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
In proliferating cells, cysteine is used for biosynthesis of glutathione, iron-sulfur clusters, and hydrogen sulfide (H2S).
“Cysteine has several metabolic fates in proliferating cells, among which are the biosynthesis of glutathione and iron-sulfur clusters, as well as of hydrogen sulfide (H2S)”
Quote in the paperNot a substantial claim - Premisecitation
Some tumor types display elevations in 2-HG even without IDH mutations.
“Notably, some tumor types display elevations in 2-HG even in the absence of IDH mutations.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Reciprocal interactions between cancer cells and their microenvironment create selective pressure that reshapes cancer cell metabolism and promotes a more aggressive state.
“Taken together, reciprocal interactions between cancer cells and their microenvironment impose a selective pressure that further shapes cancer cell metabolism and actively contributes to the emergence of a more aggressive state.”
Quote in the paperSubstantial claim - Premisecitation
Knock-in of mutant IDH1 allele into normal hematopoietic cells and chondrocytes in vivo triggers aberrant expansion of targeted cell lineages.
“Furthermore, a knock-in of a mutant IDH1 allele into normal hematopoietic cells and into chondrocytes in vivo triggers an aberrant expansion of targeted cell lineages (Hirata et al., 2015; Sasaki et al., 2012).”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
L-2-HG levels increase in response to hypoxia due to promiscuous substrate use by LDH-A and MDH.
“Furthermore, L-2-HG levels were found to increase in response to hypoxia as a result of promiscuous substrate use by LDH-A and malate dehydrogenase (MDH) (Intlekofer et al., 2015), and two recent studies implicate L-2-HG as a metabolic mediator of the cellular stress response to hypoxia (Intlekofer et al., 2015; Oldham et al., 2015).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Diets deficient in choline and betaine directly affect histone and DNA methylation in several animal models.
“Furthermore, diets deficient in choline and betaine were shown to directly affect histone and DNA methylation in a number animal models (Du et al., 2009; Mehedint et al., 2010; Niculescu et al., 2006), suggesting that alterations in exogenous methyl donor availability may have strong effects on cellular epigenetic state and thus contribute to tumorigenesis.”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
Multiple non-malignant cell types near a tumor-including fibroblasts, endothelial cells, and immune cells-show characteristic phenotypic changes when they reside close to a growing tumor.
“a variety of genetically stable cell types, among which are tumor-associated fibroblasts, endothelial cells, as well as innate and adaptive immune system components, are known to undergo characteristic phenotypic changes as a consequence of residing in the vicinity of a growing tumor (Hanahan and Coussens, 2012).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Hanahan and Coussens, 2012 source
Not checked in the free run.
- Premisecitation
Loss of tryptophan causes effector T cells to undergo apoptosis linked to amino acid deprivation.
“As a consequence, tryptophan depletion triggers amino acid deprivation-associated apoptosis of effector T cells (Fallarino et al., 2002).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Fallarino et al., 2002 source
Not checked in the free run.
- Premisecitation
In mice, colon cancer xenografts grow less when serine and glycine are absent from the diet.
“Indeed, dietary serine and glycine deficiency has been shown to impair xenograft growth of colon cancer cells in mice (Maddocks et al., 2013).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Maddocks et al., 2013 source
Not checked in the free run.
- Premisecitation
Elevated 2-HG levels have been detected in triple-negative breast cancer.
“For instance, elevated 2-HG levels have been detected in triple-negative breast cancer (Terunuma et al., 2014).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Terunuma et al., 2014 source
Not checked in the free run.
- Interpretationnone given
The study of cancer metabolism is revealing new principles of how anabolic metabolism supports normal cell growth, proliferation, and differentiation.
“Furthermore, the study of cancer metabolism is not only shedding light on carcinogenesis but is also revealing new principles of how the biochemistry of anabolic metabolism is orchestrated to support normal cell growth, proliferation, and differentiation.”
Quote in the paperNot a substantial claim - Premisecitation
Copper levels can be elevated 2-3 fold in breast and ovarian tumors and in leukemia.
“Copper levels in particular can be elevated as much as 2–3 fold in breast and ovarian tumors, as well as in leukemia (Gupte and Mumper, 2009).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Gupte and Mumper, 2009
Not checked in the free run.
- Premisecitation
Ascorbic acid treatment affects DNA methylation in embryonic stem cells and mouse embryonic fibroblasts in a TET2-dependent manner.
“Notably, ascorbic acid treatment was shown to affect DNA methylation in embryonic stem cells and mouse embryonic fibroblasts in a manner that is dependent on TET2 (Blaschke et al., 2013; Minor et al., 2013).”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
Levels of some trace metals, such as zinc and copper, differ between cancer cells and normal tissue.
“Furthermore, levels of select trace metals, such as zinc and copper, are altered in cancer cells compared to the normal tissue.”
Quote in the paperNot a substantial claim - Interpretationcitation
Alterations in exogenous methyl donor availability may strongly affect cellular epigenetic state and thereby contribute to tumorigenesis.
“suggesting that alterations in exogenous methyl donor availability may have strong effects on cellular epigenetic state and thus contribute to tumorigenesis.”
Quote in the paperSubstantial claim- Rests on an assumption: Findings from animal models about dietary methyl donors and epigenetic marks apply to human tumorigenesis.
- May combine two claims. 87
- Classified as probably not a substantial claim. 15
May combine two claims.
PremisecitationIncreased glucose consumption by tumors has been confirmed in various tumor contexts and correlates with poor prognosis.
“This observation has been confirmed in a variety of tumor contexts and shown to correlate with poor tumor prognosis”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Som et al., 1980
Not checked in the free run.
May combine two claims.
Interpretationnone givenTumorigenesis-associated metabolic alterations encompass all stages of cell-metabolite interaction: affecting nutrient influx, shaping nutrient assignment to pathways, and exerting effects on cellular fate including differentiation of cancer cells and microenvironment components.
“tumorigenesis-associated metabolic alterations encompass all stages of cell-metabolite interaction, (a) affecting the metabolite influx through conferring an increased ability to acquire the necessary nutrients; (b) shaping the way the nutrients are preferentially assigned to metabolic pathways that contribute to cellular tumorigenic properties, as well as (c) exerting long-ranging effects on”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationNormally metazoan cells do not import nutrients constitutively; nutrient uptake is strictly regulated by growth factor signaling.
“Normally, despite being surrounded by nutrient-rich plasma and the extracellular fluid, metazoan cells do not import nutrients in a constitutive manner. On the contrary, nutrient uptake is strictly regulated by growth factor signaling”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Thompson, 2011 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisereasoningControlled oxidation of glucose and glutamine carbon skeletons allows capture of reducing power as NADH/FADH2 for ATP or NADPH for biosynthesis and redox maintenance.
“controlled oxidation of carbon skeletons of glucose and glutamine allows a cell to capture their reducing power either in the form of NADH and FADH2, which mediate the transfer of electrons to the electron transport chain to fuel ATP generation, or in the form of a related cofactor NADPH, which provides reducing power for a wide variety of biosynthetic reactions, as well as helps maintain cellular”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisecitation18F-FDG PET imaging is used clinically for tumor diagnosis, staging, and monitoring treatment response.
“Positron emission tomography (PET)-based imaging of the uptake of a radioactive fluorine-labeled glucose analog, 18F-fluorodeoxyglucose (18F-FDG) has been successfully used in the clinic for tumor diagnosis and staging, as well as for monitoring responsiveness to treatment”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Almuhaideb et al., 2011
Not checked in the free run.
May combine two claims.
PremisecitationGrowth factor deprivation negatively affects cell size, mitochondrial potential, and ATP generation despite abundant glucose.
“This, in turn, negatively affects cell size, mitochondrial potential and ATP generation – all despite the abundance of glucose in the culture medium”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Rathmell et al., 2000
Not checked in the free run.
Classified as probably not a substantial claim.
PremisereasoningTo fulfill biosynthetic demands of proliferation, a cell must increase import of nutrients from the environment.
“In order to fulfill the biosynthetic demands associated with proliferation, a cell must increase the import of nutrients from the environment.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Premisenone givenGlucose and glutamine are two principal nutrients supporting survival and biosynthesis in mammalian cells.
“Two principal nutrients that support survival and biosynthesis in mammalian cells are glucose and glutamine.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationmTORC1 inhibitors greatly increase cellular ability to recover amino acids from captured extracellular protein and enhance growth in the absence of essential amino acids.
“mTORC1 inhibitors greatly increase the cellular ability to recover amino acids from captured extracellular protein and enhance their growth in the absence of essential amino acids”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Palm et al., 2015
Not checked in the free run.
May combine two claims.
PremisecitationFree amino acids can be recovered from engulfment and digestion of entire living cells via entosis and from phagocytosis of apoptotic corpses.
“free amino acids can be recovered from the engulfment and digestion of entire living cells via a process known as entosis (Figure 3B), as well as from phagocytosis of apoptotic cellular corpses”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Krajcovic et al., 2013 source
Not checked in the free run.
- cites Stolzing and Grune, 2004
Not checked in the free run.
May combine two claims.
Premisecitationc-myc induces transcription of glutamine transporters ASCT2 and SN2 and promotes expression of GLS1, PRPS2, and CAD.
“c-myc induces the transcription of glutamine transporters ASCT2 and SN2, and in addition, promotes expression of glutamine-utilizing enzymes glutaminase (GLS1), phosphoribosyl pyrophosphate synthetase (PRPS2) and carbamoyl-phosphate synthetase 2 (CAD)”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Eberhardy and Farnham, 2001
Not checked in the free run.
- cites Gao et al., 2009 source
Not checked in the free run.
- cites Mannava et al., 2008
Not checked in the free run.
May combine two claims.
PremisecitationIn KRASG12D-driven mouse pancreatic cancer, rapamycin suppresses proliferation at the tumor margin where vascular delivery is effective, but enhances proliferation in the poorly vascularized core by promoting lysosomal degradation of extracellular proteins.
“While rapamycin suppresses cancer cell proliferation at the tumor margin where the vascular delivery of nutrients is effective, rapamycin enhances cell proliferation within the poorly-vascularized tumor core by promoting enhanced lysosomal degradation of extracellular proteins”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Palm et al., 2015
Not checked in the free run.
May combine two claims.
PremisecitationSubsequent investigations show tumor cells generally possess functional mitochondria and retain the ability to conduct oxidative phosphorylation.
“subsequent investigations into the mitochondrial status of tumor cells have shown that by and large, tumor cells possess functional mitochondria and retain the ability to conduct oxidative phosphorylation.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationcitationKRAS-mutant cells may have a nutritional advantage over non-mutant neighbors and actively eliminate them.
“Thus, KRAS-mutant cells may not only have a nutritional advantage over their non-mutant neighbors, but also actively eliminate the latter.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationExogenous expression of constitutively active Akt alone can stimulate glycolysis and restore cell size, viability, mitochondrial potential, and ATP levels in growth factor-deprived cells in a glucose-dependent manner.
“exogenous expression of a constitutively active form of Akt alone can stimulate glycolysis and is sufficient to restore cell size, viability, mitochondrial potential and ATP levels in growth factor-deprived cells in a manner that is dependent upon the presence of glucose in the culture medium”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Plas et al., 2001
Not checked in the free run.
- cites Rathmell et al., 2003 source
Not checked in the free run.
May combine two claims.
InterpretationreasoningThe Warburg effect is a regulated metabolic state and may be beneficial during increased biosynthetic demand.
“These observations suggest that, rather than being an adaptation to a defect in respiration, the Warburg effect is a regulated metabolic state and may, in fact, be beneficial during a time of increased biosynthetic demand.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationDetached mammary epithelial cells have compromised glucose uptake, depressed mitochondrial potential, and decreased ATP levels.
“Culturing mammary epithelial cells under conditions where the cells are detached from the extracellular matrix compromises glucose uptake and results in a depressed mitochondrial potential and decreased ATP levels”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Grassian et al., 2011
Not checked in the free run.
- cites Schafer et al., 2009 source
Not checked in the free run.
May combine two claims.
PremisecitationAkt potentiates the activity of hexokinase and phosphofructokinase.
“Akt potentiates the activity of the hexokinase (HK), which phosphorylates glucose molecules, thus preventing their efflux back into the extracellular space, as well as of the phosphofructokinase (PFK) enzyme, which catalyzes the key irreversible step of glycolysis”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Deprez et al., 1997
Not checked in the free run.
- cites Gottlob et al., 2001
Not checked in the free run.
May combine two claims.
PremisecitationRas upregulates GLUT1 mRNA expression and increases cellular glucose consumption.
“Other oncogenic signaling proteins - notably, Ras, have been found to upregulate GLUT1 mRNA expression and increase cellular glucose consumption”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Murakami et al., 1992
Not checked in the free run.
May combine two claims.
InterpretationcitationUtilization of extracellular protein as nutrients is repressed by mTORC1 under amino acid-replete conditions and used as an emergency source when free amino acids are insufficient.
“Thus, the utilization of extracellular protein as nutrients is repressed by mTORC1 under amino acid-replete conditions and is only utilized as an emergency source in conditions when free amino acids are insufficient.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationGeneration of palmitic acid consumes 14 reducing equivalents, while building cholesterol requires 26.
“generation of palmitic acid consumes 14 reducing equivalents, while building a cholesterol molecule requires 26”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Lunt and Vander Heiden, 2011 source
Not checked in the free run.
May combine two claims.
Premisecitation18F-FDG-PET signal intensity in tumors correlates closely with PI3K/Akt pathway activity and is attenuated by PI3K and RTK inhibitors.
“the 18F-FDG-PET signal intensity in tumors correlates closely with the level of PI3K/Akt pathway activity, and is attenuated by PI-3 kinase and receptor tyrosine kinase inhibitors”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Benz et al., 2011
Not checked in the free run.
- cites Lheureux et al., 2013
Not checked in the free run.
- cites Ma et al., 2009
Not checked in the free run.
May combine two claims.
PremisecitationPI3K/Akt signaling does not promote cellular utilization of extracellular protein despite stimulating uptake of low molecular weight nutrients.
“In contrast to the effect of KRASG12D, PI3K/Akt signaling does not promote cellular utilization of extracellular protein, despite the ability of this pathway to stimulate the uptake of low molecular weight nutrients”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Palm et al., 2015
Not checked in the free run.
May combine two claims.
PremisecitationPI3K/Akt promotes GLUT1 mRNA expression and translocation of GLUT1 protein to the cell surface.
“PI3K/Akt signaling promotes both the expression of glucose transporter GLUT1 mRNA and the translocation of GLUT1 protein from the endomembranes to the cell surface”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Barthel et al., 1999
Not checked in the free run.
- cites Wieman et al., 2007
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenNADPH is a designated donor of reducing equivalents used in cellular biosynthetic reactions.
“A designated donor of reducing equivalents that is used in cellular biosynthetic reactions is NADPH.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenThe first committed step of hexosamine biosynthesis is GFPT1-catalyzed production of glucosamine-6-phosphate from fructose-6-phosphate and glutamine.
“A first committed step of hexosamine biosynthesis is a glutamine fructose-6-phospate aminotransferase 1 (GFPT1)-catalyzed production of glucosamine-6-phosphate from fructose-6-phosphate and glutamine.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationPHGDH is frequently focally amplified in breast cancer and melanoma and is required for growth of PHGDH-amplified cells in vitro and in vivo.
“A rate-limiting serine biosynthesis enzyme, 3-phosphoglycerate dehydrogenase (PHGDH), is frequently focally amplified in breast cancer and melanoma and is required for the growth of PHGDH-amplified cells in vitro as well as in vivo”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationQuiescent subpopulations of tumor cells are markedly less glycolytic and exhibit higher dependence on oxidative phosphorylation and elevated expression of mitochondrial respiratory components.
“In contrast to the proliferating bulk of a tumor, accumulating evidence suggests that quiescent subpopulations of tumor cells are markedly less glycolytic and exhibit higher dependence on oxidative phosphorylation, as well as elevated expression of mitochondrial respiratory components.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites LeBleu et al., 2014
Not checked in the free run.
- cites Viale et al., 2014 source
Not checked in the free run.
May combine two claims.
InterpretationreasoningGlycolytic intermediates leave glycolysis for biosynthetic reactions, and rate-limiting enzymes within branching pathways are frequently upregulated in tumors.
“glycolytic intermediates leave glycolysis to take part in diverse biosynthetic reactions; accordingly, the rate-limiting enzymes within branching pathways of glycolysis are frequently upregulated in tumors.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationDe novo fatty acid biosynthesis is low in normal adult tissues except lipogenic tissues, while tumorigenesis is associated with a dramatic increase in lipid production.
“While the de novo biosynthesis of fatty acids is low in normal adult tissues – with the exception of lipogenic tissues such as liver, adipose tissue or mammary epithelium in the period of lactation, tumorigenesis is associated with a dramatic increase in lipid production (Li and Cheng, 2014; Menendez and Lupu, 2007).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Li and Cheng, 2014
Not checked in the free run.
- cites Menendez and Lupu, 2007
Not checked in the free run.
May combine two claims.
PremisereasoningmGPDH uses FAD as electron acceptor and reduces net mitochondrial electrical chemical potential from glycolytic NADH.
“By using FAD as an electron acceptor, the mGPDH-catalyzed reaction reduces net mitochondrial electrical chemical potential from NADH generated via glycolysis.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationIncreased ROS levels facilitate activation of HIF1α and NRF2 transcription factors, promoting transcriptional programs that contribute to tumorigenesis.
“Furthermore, increased ROS levels facilitate the activation of HIF1α and NRF2 transcription factors, thus promoting transcriptional programs that further contribute to tumorigenesis (Bertout et al., 2008; Sporn and Liby, 2012).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Bertout et al., 2008
Not checked in the free run.
- cites Sporn and Liby, 2012 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenIn the pentose phosphate pathway, glucose-6-phosphate is partially oxidized to generate NADPH and ribose-5-phosphate.
“First in the series of these branching pathways is the pentose phosphate pathway (PPP), in which glucose-6-phosphate becomes partially oxidized to generate NADPH and ribose-5-phosphate – a structural component of nucleotides.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningBy converting excess pyruvate to lactate, proliferating cells prevent cytosolic NADH accumulation and reduce ATP production, promoting continued cytosolic glucose metabolism free from feedback repression by mitochondrial ATP.
“By converting excess pyruvate to lactate, proliferating cells prevent accumulation of cytosolic NADH and reduce ATP production promoting continued cytosolic glucose metabolism free from feedback repression by excess mitochondrial ATP generation.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationTKTL1 and TALDO are frequently overexpressed in cancer.
“The key enzymes in the pathway, transketolase-like 1 (TKTL1) and transaldolase (TALDO) are frequently overexpressed in cancer”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Wang et al., 2011a
Not checked in the free run.
- cites Xu et al., 2009b
Not checked in the free run.
Classified as probably not a substantial claim.
Premisenone givenThe last step of glycolysis is regulated by pyruvate kinase, which converts phosphoenolpyruvate to pyruvate.
“This step is regulated by pyruvate kinase (PK), an enzyme that converts phosphoenolpyruvate to the final product of glycolysis, pyruvate.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningExcess glycolytic flux not used for biosynthesis is preferentially converted to lactate to preserve NAD+ pool to sustain glycolysis and avoid flooding mitochondria with NADH that would suppress TCA cycle.
“Any excess glycolytic flux not utilized for biosynthesis is preferentially converted to lactate to help preserve a sufficient pool of NAD+ to sustain glycolysis and avoid flooding the mitochondria with a supply of NADH that would suppress the TCA cycle.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationROS act as inhibitors of protein phosphatases PTEN and PTP1B, and activators of Src family kinases and MAPK.
“To this end, ROS act as inhibitors of protein phosphatases such as PTEN and PTP1B, as well as activators of Src family kinases and MAPK (Denu and Tanner, 1998; Kamata et al., 2005; Lee et al., 2002; Yan and Berton, 1996).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Denu and Tanner, 1998
Not checked in the free run.
- cites Kamata et al., 2005 source
Not checked in the free run.
- cites Lee et al., 2002
Not checked in the free run.
May combine two claims.
Premisenone givenDHAP is converted by GPD1 into glycerol-3-phosphate, which is used in biosynthesis of diverse phospholipids.
“DHAP is converted by glycerol-3-phosphate dehydrogenase 1 (GPD1) into glycerol-3-phosphate, which is utilized in the biosynthesis of diverse phospholipids, a major structural component of cellular membranes.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationWild-type p53, but not mutant p53, inhibits the pentose phosphate pathway by directly binding and inactivating G6PD.
“wild-type, but not the mutant, p53 inhibits PPP by directly binding and inactivating the rate-limiting PPP enzyme glucose-6-phosphate dehydrogenase (G6PD)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Jiang et al., 2011
Not checked in the free run.
May combine two claims.
PremisecitationPKM2 is inhibited by tyrosine phosphorylation and activated by serine.
“Thus, PKM2 is inhibited by tyrosine phosphorylation and activated by serine (Chaneton et al., 2012; Christofk et al., 2008b; Ye et al., 2012).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Chaneton et al., 2012
Not checked in the free run.
- cites Christofk et al., 2008b
Not checked in the free run.
- cites Ye et al., 2012
Not checked in the free run.
May combine two claims.
PremisecitationPKM1 is more efficient at producing pyruvate, while the majority of proliferating cells and essentially all cancer cells express primarily PKM2.
“While PKM1 is more efficient at producing pyruvate, the majority of proliferating cells and essentially all cancer cells express primarily the PKM2 variant”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Christofk et al., 2008a
Not checked in the free run.
May combine two claims.
Premisenone givenGlycolysis is classically depicted as a single chain to pyruvate, but glycolytic intermediates can be diverted into branching pathways generating biosynthetic precursors.
“Though glycolysis is classically depicted as a single chain of molecular events that leads to the generation of pyruvate, a number of glycolytic intermediates can be diverted into branching pathways, generating diverse biosynthetic precursors.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationThe hexosamine pathway provides substrates for glycosylation, heparan sulfate, and hyaluronic acid biosynthesis, potentiates receptor-mediated signaling, and regulates stability of select proteins including c-myc.
“Through the generation of N-acetylglucosamine (GlcNAc), a substrate for N- and O-linked glycosylation, the hexosamine pathway provides substrates for cellular glycosylation reactions as well as heparan sulfate and hyaluronic acid biosynthesis, potentiates receptor-mediated signaling and regulates the stability of select proteins, including c-myc”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Itkonen et al., 2013
Not checked in the free run.
- cites Spiro, 2002
Not checked in the free run.
- cites Wellen et al., 2010
Not checked in the free run.
May combine two claims.
PremisecitationStem-like subclones emerging after oncogene ablation in vivo and circulating tumor cells are among quiescent tumor cell populations.
“Among such populations are stem-like subclones that emerge following the oncogene ablation in vivo, as well as circulating tumor cells (CTCs) (LeBleu et al., 2014; Viale et al., 2014).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites LeBleu et al., 2014
Not checked in the free run.
- cites Viale et al., 2014 source
Not checked in the free run.
May combine two claims.
PremisecitationReintroducing PKM1 compromises cancer cell proliferation and tumorigenesis in vivo, partly by negatively affecting serine-dependent biosynthesis.
“In support of this paradigm, a reintroduction of the PKM1 isoform compromises cancer cell proliferation and tumorigenesis in vivo, in part by negatively affecting serine-dependent biosynthesis (Ye et al., 2012).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ye et al., 2012
Not checked in the free run.
May combine two claims.
PremisereasoningAcetyl-CoA from citrate cleavage serves as precursor for lipid biosynthesis and protein acetylation.
“while the acetyl-CoA serves as a precursor for lipid biosynthesis and protein acetylation.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationreasoningc-myc facilitates glutamine uptake and promotes its utilization in purine and pyrimidine biogenesis.
“Thus, c-myc not only facilitates glutamine uptake, but also promotes its utilization in the biogenesis of purine and pyrimidine bases.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationCAD activity is regulated via phosphorylation by MAPK and by mTORC1-dependent S6 kinase.
“Furthermore, activity of CAD enzyme is regulated via phosphorylation by MAPK and by mTORC1-dependent S6 kinase (Ben-Sahra et al., 2013; Graves et al., 2000; Robitaille et al., 2013).”
Quote in the paperNot a substantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S4 (based). May combine two claims.
Premisenone givenGlutamine is a non-essential amino acid containing two reduced nitrogen atoms and serves as principal way reduced nitrogen is transported between cells in metazoans.
“A non-essential amino acid containing two atoms of reduced nitrogen, glutamine serves as the principal way in which reduced nitrogen is transported between cells in metazoan organisms.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisereasoningOne glutamine molecule is used in production of uracil and thymine; cytosine and adenine each require two; guanine requires three.
“Thus, one glutamine molecule is used in the production of uracil and thymine, cytosine and adenine each require two, and building a guanine base costs a cell three molecules of glutamine.”
Quote in the paperSubstantial claimMay combine two claims.
Premisenone givenGlutamine can be directly deamidated to glutamate by glutaminase, which is frequently upregulated in cancer cells in a c-myc-dependent manner.
“In addition to being utilized for nucleotide biosynthesis, glutamine can be directly deamidated to glutamate by glutaminase which is frequently upregulated in cancer cells in a c-myc-dependent manner.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationASNS is frequently upregulated in tumors and associated with poor prognosis.
“ASNS is frequently upregulated in tumors and is associated with poor prognosis (Sircar et al., 2012; Zhang et al., 2014).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Sircar et al., 2012
Not checked in the free run.
- cites Zhang et al., 2014 source
Not checked in the free run.
May combine two claims.
Premisenone givenImported acetate is converted to acetyl-CoA by ACSS2, which is a target for amplification in breast cancer.
“Imported acetate is converted to acetyl-CoA in a reaction catalyzed by acetyl-CoA synthetase 2 (ACSS2), which is a target for amplification in breast cancer.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationACLY, ACC, and FASN are frequently upregulated in transformed cells, and their inhibition reduces tumor cell growth in vitro and in vivo.
“In fact, all three major components involved in fatty acyl chain biosynthesis – ACLY, ACC and FASN – are frequently upregulated in transformed cells; furthermore, their inhibition reduces tumor cell growth in vitro and in vivo (Chajes et al., 2006; Flavin et al., 2010; Migita et al., 2008; Milgraum et al., 1997).”
Quote in the paperSubstantial claim0 of 3 sources checkedMay combine two claims.
InterpretationreasoningCell lineage context and potential secondary effects of adaptation to tissue culture may play important role in choice of anaplerotic substrate.
“These reports highlight that the cell lineage context, as well as potential secondary effects associated with the adaptation of cells to tissue culture conditions may play an important role in the choice of an anaplerotic substrate.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationReductive carboxylation reverses a section of TCA cycle, converting α-ketoglutarate into citrate, which can generate cytosolic acetyl-CoA.
“In a process referred to as reductive carboxylation, a section of the TCA cycle reverses itself, converting α-ketoglutarate into citrate, which can be then used to generate a source of cytosolic acetyl-CoA (Metallo et al., 2012; Wise et al., 2011).”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
Premisenone givenGlutamine is captured in mitochondria by glutaminase and resulting glutamate converted to α-ketoglutarate by glutamate dehydrogenase or amino acid transaminases.
“Glutamine can be captured in mitochondria by glutaminase and the resulting glutamate converted into α-ketoglutarate by either glutamate dehydrogenase or amino acid transaminases.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationIncreased capacity for de novo lipid production facilitates lipid bilayer formation and enables altering membrane composition toward oxidative damage-resistant saturated fatty acids to adapt to oxidative stress.
“An increased capacity for the producing lipids de novo not only facilitates the formation of lipid bilayers, but also enables a cell to alter its membrane composition in favor of oxidative damage-resistant saturated fatty acids as means of adapting to oxidative stress (Rysman et al., 2010).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Rysman et al., 2010
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisenone givenArginine carries four nitrogen atoms and serves as precursor for polyamines, creatine, agmatine, and pyrroline-5-carboxylate.
“A carrier of four nitrogen atoms, arginine serves as a precursor for a wide variety of nitrogenous compounds, among which are polyamines, creatine, agmatine and pyrroline-5-carboxylate, a precursor for the biosynthesis of proline.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationPC inhibition in NSCLC-derived cell lines suppresses fatty acid biosynthesis and reduces proliferation even with ample glutamine.
“Moreover, PC inhibition in NSCLC-derived cell lines suppresses fatty acid biosynthesis and dramatically reduces proliferation even in the presence of ample glutamine (Sellers et al., 2015).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Sellers et al., 2015
Not checked in the free run.
May combine two claims.
InterpretationreasoningHypoxia-associated acetyl-CoA deficit can be augmented by reductive carboxylation of α-ketoglutarate and by increasing utilization of free acetate from plasma and interstitial fluid.
“Thus, hypoxia-associated deficit of acetyl-CoA can be augmented not only through the reductive carboxylation of α-ketoglutarate, but also by increasing the utilization of free acetate from plasma and interstitial fluid.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationIn c-myc-transformed cells, glutamine deprivation leads to TCA cycle collapse and cell death, which can be rescued by oxaloacetate or membrane-permeable α-ketoglutarate.
“In c-myc-transformed cells in particular, glutamine deprivation leads to the collapse of the TCA cycle and triggers cell death, which can be rescued by the addition of oxaloacetate or a membrane-permeable form of α-ketoglutarate (Wise et al., 2008; Yuneva et al., 2007).”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationPolyamine levels increase in proliferating cells, and polyamines inhibit apoptosis and promote tumor growth and invasion.
“Polyamine levels increase in proliferating cells; moreover, polyamines have been shown to inhibit apoptosis and promote tumor growth and invasion (Casero and Marton, 2007; Gerner and Meyskens, 2004).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Casero and Marton, 2007
Not checked in the free run.
- cites Gerner and Meyskens, 2004
Not checked in the free run.
Classified as probably not a substantial claim.
InterpretationreasoningInactivation of ASL and ASS1 may allow cancer cells to accumulate ornithine, which is used for polyamine production.
“One possibility is that the inactivation of ASL and ASS1 allows cancer cells to accumulate ornithine, which is then utilized in the production of polyamines, a class of nitrogen-containing polycationic aliphatic carbon molecules.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationSirtuins utilize NAD+ as cofactor; LSD1 uses FAD as cofactor.
“For instance, sirtuins, a class of deacetylases that catalyze the removal of acetyl marks from histone and non-histone proteins, utilize NAD+ as a cofactor, while FAD serves as a cofactor for a lysine-specific demethylase LSD1 (Imai et al., 2000; Shi et al., 2004).”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationPOX mediates proline degradation, is negatively controlled by c-myc via miR-23b, and is a p53 target.
“Reciprocally, proline oxidase (POX), which mediates proline degradation, is negatively controlled by c-myc via miR-23b, and is a p53 target as well (Donald et al., 2001; Liu et al., 2012).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Donald et al., 2001
Not checked in the free run.
- cites Liu et al., 2012
Not checked in the free run.
May combine two claims.
Premisenone givenAmong α-ketoglutarate-dependent dioxygenases are TET DNA demethylases, Jumonji C histone demethylases, mRNA demethylases FTO and ALKBH5, and PHD enzymes regulating HIF1α.
“Among α-ketoglutarate-dependent dioxygenases are a TET family of DNA demethylases, Jumonji C family of histone demethylases, mRNA demethylases FTO and ALKBH5, and a family of prolyl hydroxylase (PHD) enzymes, which, among other processes, regulate HIF1α levels in response to oxygen availability and oxidative stress.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenArgininosuccinate is produced by ASS1 from citrulline and aspartate.
“Argininosuccinate, in turn, is produced by the enzyme argininosuccinate synthase (ASS1) from citrulline and aspartate.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisereasoningSAM is product of one-carbon metabolic pathway and is fueled by serine catabolism.
“SAM is a product of the one-carbon metabolic pathway and is fueled by serine catabolism as described above.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationTumors with SDH and FH loss share phenotypic features consistent with dioxygenase inhibition, including global increase in DNA methylation and elevated HIF1α.
“Tumors that exhibit SDH- and FH loss share a number of phenotypic features that are consistent with dioxygenase inhibition, among which is a characteristic global increase in DNA methylation (Killian et al., 2013; Letouze et al., 2013; Xiao et al., 2012), as well as elevated levels of HIF1α (Selak et al., 2005).”
Quote in the paperSubstantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenProline can be produced from glutamate or arginine-derived ornithine via a common intermediate, pyrroline-5-carboxylate.
“Proline can be produced either from glutamate or from arginine-derived ornithine via a common intermediate, pyrroline-5-carboxylate.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationWithdrawal and readdition of glucose, and activation of oncogenic KRAS or Akt, increase total histone acetylation, promoting enhanced and broader gene expression.
“Indeed, withdrawal and readdition of glucose, as well as activation of oncogenic signaling via introduction of an oncogenic KRAS mutant or a constitutively active form of Akt, increase total histone acetylation, which, in turn, promotes the enhanced and broader gene expression (Lee et al., 2014).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Lee et al., 2014 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisenone givenDe novo arginine biosynthesis is part of urea cycle, derived from argininosuccinate by ASL.
“The de novo biosynthesis of arginine is an integral part of the urea cycle, where it is derived from argininosuccinate in a cleavage reaction catalyzed by argininosuccinate lyase (ASL).”
Quote in the paperNot a substantial claimMay combine two claims.
Premisenone givenDeposition of acetyl marks on histones is associated with increased DNA accessibility for transcriptional complexes and has rapid turnover.
“The deposition of acetyl marks on histones is associated with the increased accessibility of the genomic DNA for the assembly of transcriptional complexes, and has a rapid turnover rate.”
Quote in the paperSubstantial claimMay combine two claims.
PremisereasoningTumors often encounter low nutrient and oxygen levels and develop nutrient-scavenging strategies to overcome these limitations.
“As discussed earlier, tumors are often faced with nutrient- and oxygen-poor surroundings and develop various nutrient-scavenging strategies to bypass these limitations.”
Quote in the paperSubstantial claimMay combine two claims.
Premisenone givenHypoxia prevents oxidative phosphorylation and other oxygen-requiring reactions, disrupts redox balance, and affects cellular signaling and transcriptional programs.
“Furthermore, hypoxia impedes the ability of cells to carry out oxidative phosphorylation and other reactions that require oxygen and disrupts the redox balance, affecting cellular signaling and transcriptional programs.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationH2S has complex, incompletely defined roles in cells, such as defending against oxidative stress, boosting mitochondrial respiration, preventing apoptosis, and supporting angiogenesis.
“a gasotransmitter with complex and not yet fully defined functions in cellular physiology, among which are protection from oxidative stress, increased mitochondrial respiration, protection from apoptosis and facilitation of angiogenesis (Wu et al., 2015).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Wu et al., 2015
Not checked in the free run.
May combine two claims.
Interpretationnone givenOncogene-driven metabolic reprogramming enables cancer cells to sustain deregulated proliferation, survive oxygen and nutrient limitations, maintain a dedifferentiated state via altered global gene expression, and corrupt the surrounding microenvironment to support tumor growth and spread.
“Oncogene-driven metabolic reprogramming allows cancer cells to maintain deregulated proliferation, withstand metabolic challenges that are associated with oxygen and nutrient limitations, maintain a dedifferentiated state through alterations in global patterns of gene expression, and corrupt the surrounding microenvironment into actively assisting tumor growth and dissemination.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIncreased extracellular acidification stimulates MMP and cathepsin proteolytic activity, which degrades extracellular matrix components and enhances tumor invasion.
“Increased extracellular acidification stimulates the proteolytic activity of matrix metalloproteinases (MMPs) and cathepsins, promoting the degradation of the extracellular matrix components and enhancing tumor invasion (Martinez-Zaguilan et al., 1996; Rothberg et al., 2013).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Martinez-Zaguilan et al., 1996
Not checked in the free run.
- cites Rothberg et al., 2013
Not checked in the free run.
May combine two claims.
PremisecitationCancer cells increase cysteine uptake by transcriptionally upregulating the xCT transporter and as a secondary consequence of increased glutamine utilization.
“Thus, cancer cells upregulate the uptake of cysteine via the transcriptional upregulation of the xCT transporter, as well as secondary to the increased rate of glutamine utilization by cells (Lo et al., 2008).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Lo et al., 2008
Not checked in the free run.
May combine two claims.
PremisecitationIn endothelial cells, lactate enhances HIF1α stability and turns on NF-κB and PI-3 kinase signaling; it also causes stromal cells near tumors to release VEGF.
“Thus, lactate promotes the stabilization of HIF1α and activates NF-κB and PI-3 kinase signaling in endothelial cells, as well as induces secretion of a pro-angiogenic factor VEGF from tumor-associated stromal cells (Constant et al., 2000; Schmid et al., 2007; Sonveaux et al., 2012; Vegran et al., 2011).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Constant et al., 2000 source
Not checked in the free run.
- cites Schmid et al., 2007
Not checked in the free run.
- cites Sonveaux et al., 2012
Not checked in the free run.
May combine two claims.
InterpretationreasoningCancer cells reprogram their microenvironment to support tumor growth and spread through multiple mechanisms, including secreted growth factors, changes to the extracellular matrix, and altered cell-cell interactions.
“How cancer cells reprogram their microenvironment to assist tumor growth and dissemination is an area of intense investigation, but it is clear that such reprogramming encompasses multiple strategies, among which are secreted growth factors and alterations to the extracellular matrix and cell-cell interactions.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationSpecific increase in L-2-HG found in clear cell renal cell carcinoma, where it correlates with increased methylcytosine levels.
“In addition, a specific increase in the L enantiomer of 2-HG, which was shown to exert similar, but not identical, inhibitory effects on α-ketoglutarate-dependent dioxygenases was found in clear cell renal cell carcinoma, where it correlates with increased methylcytosine levels (Shim et al., 2014).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Shim et al., 2014 source
Not checked in the free run.
May combine two claims.
PremisecitationBreast and prostate tumors take up more choline, and radiolabeled choline (18F or 11C) is used in clinical PET imaging of tumors.
“Increased choline uptake is observed in breast and prostate cancer; in fact, radioactive 18F- and 11C-choline is used in the clinic for PET-based tumor imaging (Krause et al., 2013; Kwee et al., 2007).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Krause et al., 2013
Not checked in the free run.
- cites Kwee et al., 2007
Not checked in the free run.
May combine two claims.
PremisecitationEctopic expression of mutant IDH allele or treatment with exogenous D-2-HG induces DNA and histone hypermethylation and blocks cellular differentiation.
“In various cellular settings, ectopic expression of a mutant IDH allele or treatment with exogenous D-2-HG is sufficient to induce DNA and histone hypermethylation and block cellular differentiation (Losman et al., 2013; Lu et al., 2012).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Losman et al., 2013 source
Not checked in the free run.
- cites Lu et al., 2012
Not checked in the free run.
May combine two claims.
PremisecitationIncreased lactate stimulates fibroblasts to produce hyaluronic acid, which may contribute to tumor invasiveness.
“Increased levels of lactate also stimulate hyaluronic acid production by fibroblasts, which may contribute to tumor invasiveness (Stern et al., 2002).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Stern et al., 2002
Not checked in the free run.
May combine two claims.
PremisecitationSome tumors use a distinct strategy to create an immune-permissive microenvironment: many solid tumor types overexpress the tryptophan-degrading enzymes IDO1 and TDO2, which convert tryptophan to kynurenine.
“Specifically, numerous solid tumor types overexpress tryptophan-degrading dioxygenases indoleamine-2, 3-dioxygenase (IDO1) and tryptophan-2, 3-dioxygenase (TDO2), which catalyze the conversion of an essential amino acid, tryptophan, into its derivative, kynurenine (Munn and Mellor, 2007).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Munn and Mellor, 2007
Not checked in the free run.
May combine two claims.
PremisecitationHigher lactate concentrations create a microenvironment that favors immune tolerance, reducing activation of dendritic cells and T cells and impairing monocyte movement.
“Increased lactate levels promote the emergence of an immune-permissive microenvironment by attenuating dendritic and T cell activation and monocyte migration (Fischer et al., 2007; Goetze et al., 2011; Gottfried et al., 2006).”
Quote in the paperSubstantial claim0 of 3 sources checkedMay combine two claims.
PremisecitationLactate drives resident macrophages toward an M2-like state, which contributes to immunosuppression and wound healing.
“In addition, lactate stimulates the polarization of resident macrophages to a so-called M2 state, which plays a role in immunosuppression and wound healing (Carmona-Fontaine et al., 2013; Colegio et al., 2014).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Carmona-Fontaine et al., 2013
Not checked in the free run.
- cites Colegio et al., 2014 source
Not checked in the free run.
May combine two claims.
PremisecitationKynurenine enhances autocrine AhR signaling in cancer cells, promoting extracellular matrix degradation and invasion.
“Finally, kynurenine potentiates autocrine signaling through AhR on cancer cells themselves, promoting the degradation of the extracellular matrix and invasion (Opitz et al., 2011).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Opitz et al., 2011
Not checked in the free run.
May combine two claims.
Premisenone givenMost research has centered on glucose and glutamine, yet cancer cells also consume many other nutrients, including choline, trace metals, vitamins, essential fatty acids, and sulfur-containing amino acids.
“While most of the studies to this point have been focused on alterations in the metabolism of glucose and glutamine, cancer cells utilize a great variety of other nutrients, among which are sulfur–containing amino acids cysteine and methionine, essential fatty acids, choline, trace metals, and vitamins.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIDH mutations in AML are mutually exclusive with inactivating TET2 mutations, implicating mutant IDH as driver of epigenetic remodeling.
“IDH mutations in AML are mutually exclusive with inactivating mutations in TET2 methylcytosine hydroxylases, further implicating mutant IDH as a bona fide driver of epigenetic remodeling (Figueroa et al., 2010).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Figueroa et al., 2010 source
Not checked in the free run.
May combine two claims.
PremisecitationIn an AhR-dependent manner, kynurenine promotes a regulatory T-cell phenotype, further suppressing antitumor immune responses.
“In a manner that is dependent on AhR, kynurenine promotes regulatory T-cell phenotype, further contributing to the suppression of antitumor immune responses (Fallarino et al., 2006).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Fallarino et al., 2006
Not checked in the free run.
May combine two claims.
Premisenone givenMicronutrients such as vitamins and trace metals are used as enzyme cofactors and have complex, not fully defined roles in regulating metabolic circuits and signal transduction.
“Micronutrients are utilized as cofactors for various enzymes and play complex and not yet fully defined roles in regulating cellular metabolic circuits, as well as signal transduction.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIn melanoma cells, BRAFV600E-driven ERK activation needs copper; forcing ERK activation rescues the effects of copper depletion.
“Interestingly, copper was recently shown to be required for BRAFV600E-driven ERK activation in melanoma cells, and the effect of copper depletion could be rescued by the constitutive activation of ERK (Brady et al., 2014).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Brady et al., 2014
Not checked in the free run.
May combine two claims.
InterpretationreasoningMany cancers have increased methylation of CpG islands, so altered ascorbic acid import may affect their epigenetic state.
“As many cancers are characterized by increased methylation of CpG islands, alterations in ascorbic acid import may thus affect their epigenetic state as well.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenAscorbic acid serves as a cofactor for dioxygenases that depend on α-ketoglutarate.
“For instance, ascorbic acid acts as a cofactor for the α-ketoglutarate-dependent dioxygenases.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
Most tumors display several of the six metabolic hallmarks, while few display all six.
“While few tumors display all six hallmarks, most display several.”
The paper relies on this without support.
Findings from animal models about dietary methyl donors and epigenetic marks apply to human tumorigenesis.
“Furthermore, diets deficient in choline and betaine were shown to directly affect histone and DNA methylation in a number animal models (Du et al., 2009; Mehedint et al., 2010; Niculescu et al., 2006), suggesting that alterations in exogenous methyl donor availability may have strong effects on cellular epigenetic state and thus contribute to tumorigenesis.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
TCA cycle intermediates are not solely used to produce NADH for mitochondrial respiration; they can also be used to form nonessential amino acids and fatty acids, which facilitate protein synthesis, membrane construction, and cholesterol synthesis.
“Even TCA cycle intermediates are not solely used to produce NADH for mitochondrial respiration, but intermediates can also be used to form nonessential amino acids and fatty acids, which facilitate protein synthesis, membrane construction and cholesterol synthesis (206).”
From Metabolic Flexibility as an Adaptation to Energy Resources and Requirements in Health and Disease (2018) · cites this paper as [206]
The PPP is chiefly used for NADPH and ribose synthesis to produce nucleotides.
“The PPP is chiefly used for NADPH and ribose synthesis to produce nucleotides (206).”
From Metabolic Flexibility as an Adaptation to Energy Resources and Requirements in Health and Disease (2018) · cites this paper as [206]
Not all tumors are glutamine dependent because some tumors and embryonic stem cells are capable of proliferation without an exogenous supply of glutamine, because they can synthesize it.
“However, not all tumors are glutamine dependent because some tumors and embryonic stem cells are capable of proliferation without an exogenous supply of glutamine, because they can synthesize it (206).”
From Metabolic Flexibility as an Adaptation to Energy Resources and Requirements in Health and Disease (2018) · cites this paper as [206]
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219 · see citing works
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y., Jiang, Q. L., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,351 · see citing works
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197 · see citing works
Self-citationWarburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425 · see citing works
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857 · see citing works
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632 · see citing works
The metabolism of tumors in the body
Warburg, O., Wind, F., & Negelein, E. (1927) · Journal of General Physiology · doi:10.1085/jgp.8.6.519 · Cited by 4,416 · see citing works
Cancer genes and the pathways they control
Vogelstein, B., & Kinzler, K. W. (2004) · Nature Medicine · doi:10.1038/nm1087 · Cited by 4,245 · see citing works
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154 · see citing works
Self-citationHistone demethylation mediated by the nuclear amine oxidase homolog LSD1
Shi, Y., Lan, F., Matson, C., Mulligan, P., Whetstine, J. R., Cole, P. A., Casero, R. A., & Shi, Y. (2004) · Cell · doi:10.1016/j.cell.2004.12.012 · Cited by 4,051 · see citing works
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905 · see citing works
Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
Imai, S.-I., Armstrong, C. M., Kaeberlein, M., & Guarente, L. (2000) · Nature · doi:10.1038/35001622 · Cited by 3,510 · see citing works
(1989) · PubMed · Cited by 3,343 · see citing works
Aerobic glycolysis: Meeting the metabolic requirements of cell proliferation
Lunt, S. Y., & Vander Heiden, M. G. (2011) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-092910-154237 · Cited by 3,057 · see citing works
Functional Polarization of Tumour-Associated Macrophages by Tumour-Derived Lactic Acid
Colegio, O. R., Chu, N.-Q., Szabo, A. L., Chu, T., Rhebergen, A. M., Jairam, V., Cyrus, N., Brokowski, C. E., Eisenbarth, S. C., Phillips, G. M., et al. (2014) · Nature · doi:10.1038/nature13490 · Cited by 3,046 · see citing works
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Menendez, J. A., & Lupu, R. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2222 · Cited by 2,941 · see citing works
Xu, W., Yang, H., Liu, Y., Yang, Y., Wang, P., Kim, S.-H., Ito, S., Yang, C., Wang, P., Xiao, M.-T., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.12.014 · Cited by 2,875 · see citing works
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820 · see citing works
Figueroa, M. E., Abdel-Wahab, O., Lu, C., Ward, P. S., Patel, J., Shih, A., Li, Y., Bhagwat, N., Vasanthakumar, A., Fernandez, H. F., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.11.015 · Cited by 2,766 · see citing works
Self-citationDeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622 · see citing works
Self-citationATP-citrate lyase links cellular metabolism to histone acetylation
Wellen, K. E., Hatzivassiliou, G., Sachdeva, U. M., Bui, T. V., Cross, J. R., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1164097 · Cited by 2,298 · see citing works
Self-citationAdipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
Nieman, K. M., Kenny, H. A., Penicka, C. V., Ladanyi, A., Buell-Gutbrod, R., Zillhardt, M. R., Romero, I. L., Carey, M. S., Mills, G. B., Hotamisligil, G. S., et al. (2011) · Nature Medicine · doi:10.1038/nm.2492 · Cited by 2,279 · see citing works
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L., & Denko, N. C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.012 · Cited by 2,267 · see citing works
Recurring mutations found by sequencing an acute myeloid leukemia genome
Mardis, E. R., Ding, L., Dooling, D. J., Larson, D. E., McLellan, M. D., Chen, K., Koboldt, D. C., Fulton, R. S., Delehaunty, K. D., McGrath, S. D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0903840 · Cited by 2,219 · see citing works
The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation
Wang, R., Dillon, C. P., Shi, L. Z., Milasta, S., Carter, R., Finkelstein, D., McCormick, L. L., Fitzgerald, P., Chi, H., Munger, J., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.09.021 · Cited by 2,140 · see citing works
Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124 · see citing works
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase
Selak, M. A., Armour, S. M., MacKenzie, E. D., Boulahbel, H., Watson, D. G., Mansfield, K. D., Pan, Y., Simon, M. C., Thompson, C. B., & Gottlieb, E. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.11.022 · Cited by 2,108 · see citing works
Self-citationOncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism
Ying, H., Kimmelman, A. C., Lyssiotis, C. A., Hua, S., Chu, G. C., Fletcher-Sananikone, E., Locasale, J. W., Son, J., Zhang, H., Coloff, J. L., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.058 · Cited by 2,043 · see citing works
Ward, P. S., Patel, J., Wise, D. R., Abdel-Wahab, O., Bennett, B. D., Coller, H. A., Cross, J. R., Fantin, V. R., Hedvat, C. V., Perl, A. E., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.01.020 · Cited by 2,020 · see citing works
Self-citationWise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001 · see citing works
Self-citationGlutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
Son, J., Lyssiotis, C. A., Ying, H., Wang, X., Hua, S., Ligorio, M., Perera, R. M., Ferrone, C. R., Mullarky, E., Shyh-Chang, N., et al. (2013) · Nature · doi:10.1038/nature12040 · Cited by 1,990 · see citing works
IDH mutation impairs histone demethylation and results in a block to cell differentiation
Lu, C., Ward, P. S., Kapoor, G. S., Rohle, D., Turcan, S., Abdel-Wahab, O., Edwards, C. R., Khanin, R., Figueroa, M. E., Melnick, A., et al. (2012) · Nature · doi:10.1038/nature10860 · Cited by 1,985 · see citing works
Self-citationIDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
Turcan, S., Rohle, D., Goenka, A., Walsh, L. A., Fang, F., Yilmaz, E., Campos, C., Fabius, A. W. M., Lu, C., Ward, P. S., et al. (2012) · Nature · doi:10.1038/nature10866 · Cited by 1,974 · see citing works
Self-citationInhibitory effect of tumor cell-derived lactic acid on human T cells
Fischer, K., Hoffmann, P., Voelkl, S., Meidenbauer, N., Ammer, J., Edinger, M., Gottfried, E., Schwarz, S., Rothe, G., Hoves, S., et al. (2007) · Blood · doi:10.1182/blood-2006-07-035972 · Cited by 1,946 · see citing works
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
Opitz, C. A., Litzenburger, U. M., Sahm, F., Ott, M., Tritschler, I., Trump, S., Schumacher, T., Jestaedt, L., Schrenk, D., Weller, M., et al. (2011) · Nature · doi:10.1038/nature10491 · Cited by 1,898 · see citing works
Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy
Nicklin, P., Bergman, P., Zhang, B., Triantafellow, E., Wang, H., Nyfeler, B., Yang, H., Hild, M., Kung, C., Wilson, C., et al. (2009) · Cell · doi:10.1016/j.cell.2008.11.044 · Cited by 1,798 · see citing works
Kamata, H., Honda, S.-I., Maeda, S., Chang, L., Hirata, H., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2004.12.041 · Cited by 1,792 · see citing works
Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia
Metallo, C. M., Gameiro, P. A., Bell, E. L., Mattaini, K. R., Yang, J., Hiller, K., Jewell, C. M., Johnson, Z. R., Irvine, D. J., Guarente, L., et al. (2012) · Nature · doi:10.1038/nature10602 · Cited by 1,791 · see citing works
Functional genomics reveal that the serine synthesis pathway is essential in breast cancer
Possemato, R., Marks, K. M., Shaul, Y. D., Pacold, M. E., Kim, D., Birsoy, K., Sethumadhavan, S., Woo, H.-K., Jang, H. G., Jha, A. K., et al. (2011) · Nature · doi:10.1038/nature10350 · Cited by 1,683 · see citing works
Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells
Commisso, C., Davidson, S. M., Soydaner-Azeloglu, R. G., Parker, S. J., Kamphorst, J. J., Hackett, S., Grabocka, E., Nofal, M., Drebin, J. A., Thompson, C. B., et al. (2013) · Nature · doi:10.1038/nature12138 · Cited by 1,683 · see citing works
Self-citationThe Multiple Leiomyoma Consortium (2002) · Nature Genetics · doi:10.1038/ng849 · Cited by 1,635 · see citing works
Growth factor regulation of autophagy and cell survival in the absence of apoptosis
Lum, J. J., Bauer, D. E., Kong, M., Harris, M. H., Li, C., Lindsten, T., & Thompson, C. B. (2005) · Cell · doi:10.1016/j.cell.2004.11.046 · Cited by 1,487 · see citing works
Self-citationSpiro, R. G. (2002) · Glycobiology · doi:10.1093/glycob/12.4.43r · Cited by 1,414 · see citing works
LeBleu, V. S., O’Connell, J. T., Herrera, K. N. G., Wikman, H., Pantel, K., Haigis, M. C., de Carvalho, F. M., Damascena, A. S., Chinen, L. T. D., Rocha, R. M., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3039 · Cited by 1,412 · see citing works
Garrett, W. S. (2015) · Science · doi:10.1126/science.aaa4972 · Cited by 1,404 · see citing works
Birsoy, K., Wang, T., Chen, W. W., Freinkman, E., Abu-Remaileh, M., & Sabatini, D. M. (2015) · Cell · doi:10.1016/j.cell.2015.07.016 · Cited by 1,388 · see citing works
The impact of O2 availability on human cancer
Bertout, J. A., Patel, S. A., & Simon, M. C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2540 · Cited by 1,365 · see citing works
Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function
Viale, A., Pettazzoni, P., Lyssiotis, C. A., Ying, H., Sánchez, N., Marchesini, M., Carugo, A., Green, T., Seth, S., Giuliani, V., et al. (2014) · Nature · doi:10.1038/nature13611 · Cited by 1,259 · see citing works
Emerging regulation and functions of autophagy
Boya, P., Reggiori, F., & Codogno, P. (2013) · Nature Cell Biology · doi:10.1038/ncb2788 · Cited by 1,216 · see citing works
Xiao, M., Yang, H., Xu, W., Ma, S., Lin, H., Zhu, H., Liu, L., Liu, Y., Yang, C., Xu, Y., et al. (2012) · Genes & Development · doi:10.1101/gad.191056.112 · Cited by 1,188 · see citing works
Supporting aspartate biosynthesis is an essential function of respiration in proliferating cells
Sullivan, L. B., Gui, D. Y., Hosios, A. M., Bush, L. N., Freinkman, E., & Vander Heiden, M. G. (2015) · Cell · doi:10.1016/j.cell.2015.07.017 · Cited by 1,173 · see citing works
Polyamines and cancer: old molecules, new understanding
Gerner, E. W., & Meyskens, F. L. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1454 · Cited by 1,163 · see citing works
An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells
Rohle, D., Popovici-Muller, J., Palaskas, N., Turcan, S., Grommes, C., Campos, C., Tsoi, J., Clark, O., Oldrini, B., Komisopoulou, E., et al. (2013) · Science · doi:10.1126/science.1236062 · Cited by 1,153 · see citing works
Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis
Locasale, J. W., Grassian, A. R., Melman, T., Lyssiotis, C. A., Mattaini, K. R., Bass, A. J., Heffron, G., Metallo, C. M., Muranen, T., Sharfi, H., et al. (2011) · Nature Genetics · doi:10.1038/ng.890 · Cited by 1,120 · see citing works
Quantitative flux analysis reveals folate-dependent NADPH production
Fan, J., Ye, J., Kamphorst, J. J., Shlomi, T., Thompson, C. B., & Rabinowitz, J. D. (2014) · Nature · doi:10.1038/nature13236 · Cited by 1,114 · see citing works
Self-citationAstuti, D., Latif, F., Dallol, A., Dahia, P. L. M., Douglas, F., George, E., Sköldberg, F., Husebye, E. S., Eng, C., & Maher, E. R. (2001) · The American Journal of Human Genetics · doi:10.1086/321282 · Cited by 1,087 · see citing works
Indoleamine 2,3-dioxygenase and tumor-induced tolerance
Munn, D. H., & Mellor, A. L. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31178 · Cited by 1,074 · see citing works
NRF2 and cancer: the good, the bad and the importance of context
Sporn, M. B., & Liby, K. T. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3278 · Cited by 1,067 · see citing works
Reversible Inactivation of the Tumor Suppressor PTEN by H2O2
Lee, S.-R., Yang, K., Kwon, J., Lee, C., Jeong, W., & Rhee, S. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111899200 · Cited by 1,061 · see citing works
Fallarino, F., Grohmann, U., You, S., McGrath, B. C., Cavener, D. R., Vacca, C., Orabona, C., Bianchi, R., Belladonna, M. L., Volpi, C., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.11.6752 · Cited by 1,042 · see citing works
Analysis of the IDH1 codon 132 mutation in brain tumors
Balss, J., Meyer, J., Mueller, W., Korshunov, A., Hartmann, C., & von Deimling, A. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0455-2 · Cited by 1,036 · see citing works
Elevated copper and oxidative stress in cancer cells as a target for cancer treatment
Gupte, A., & Mumper, R. J. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.07.004 · Cited by 1,036 · see citing works
Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment
Schafer, Z. T., Grassian, A. R., Song, L., Jiang, Z., Gerhart-Hines, Z., Irie, H. Y., Gao, S., Puigserver, P., & Brugge, J. S. (2009) · Nature · doi:10.1038/nature08268 · Cited by 1,031 · see citing works
T cell apoptosis by tryptophan catabolism
Fallarino, F., Grohmann, U., Vacca, C., Bianchi, R., Orabona, C., Spreca, A., Fioretti, M. C., & Puccetti, P. (2002) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401073 · Cited by 1,022 · see citing works
Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells
Maddocks, O. D. K., Berkers, C. R., Mason, S. M., Zheng, L., Blyth, K., Gottlieb, E., & Vousden, K. H. (2013) · Nature · doi:10.1038/nature11743 · Cited by 1,007 · see citing works
Intracellular α-ketoglutarate maintains the pluripotency of embryonic stem cells
Carey, B. W., Finley, L. W. S., Cross, J. R., Allis, C. D., & Thompson, C. B. (2015) · Nature · doi:10.1038/nature13981 · Cited by 1,007 · see citing works
Self-citationMonoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis
Nomura, D. K., Long, J. Z., Niessen, S., Hoover, H. S., Ng, S.-W., & Cravatt, B. F. (2010) · Cell · doi:10.1016/j.cell.2009.11.027 · Cited by 1,002 · see citing works
Pyruvate kinase M2 is a phosphotyrosine-binding protein
Christofk, H. R., Vander Heiden, M. G., Wu, N., Asara, J. M., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06667 · Cited by 995 · see citing works
Wise, D. R., Ward, P. S., Shay, J. E. S., Cross, J. R., Gruber, J. J., Sachdeva, U. M., Platt, J. M., DeMatteo, R. G., Simon, M. C., & Thompson, C. B. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117773108 · Cited by 975 · see citing works
Self-citationGottlob, K., Majewski, N., Kennedy, S., Kandel, E., Robey, R. B., & Hay, N. (2001) · Genes & Development · doi:10.1101/gad.889901 · Cited by 961 · see citing works
Denu, J. M., & Tanner, K. G. (1998) · Biochemistry · doi:10.1021/bi973035t · Cited by 945 · see citing works
Kamphorst, J. J., Nofal, M., Commisso, C., Hackett, S. R., Lu, W., Grabocka, E., Vander Heiden, M. G., Miller, G., Drebin, J. A., Bar-Sagi, D., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2211 · Cited by 893 · see citing works
Self-citationVitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells
Blaschke, K., Ebata, K. T., Karimi, M. M., Zepeda-Martínez, J. A., Goyal, P., Mahapatra, S., Tam, A., Laird, D. J., Hirst, M., Rao, A., et al. (2013) · Nature · doi:10.1038/nature12362 · Cited by 865 · see citing works
Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway
Freed-Pastor, W. A., Mizuno, H., Zhao, X., Langerød, A., Moon, S.-H., Rodriguez-Barrueco, R., Barsotti, A., Chicas, A., Li, W., Polotskaia, A., et al. (2012) · Cell · doi:10.1016/j.cell.2011.12.017 · Cited by 865 · see citing works
2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas
Choi, C., Ganji, S. K., DeBerardinis, R. J., Hatanpaa, K. J., Rakheja, D., Kovacs, Z., Yang, X.-L., Mashimo, T., Raisanen, J. M., Marin-Valencia, I., et al. (2012) · Nature Medicine · doi:10.1038/nm.2682 · Cited by 839 · see citing works
Schug, Z. T., Peck, B., Jones, D. T., Zhang, Q., Grosskurth, S., Alam, I. S., Goodwin, L. M., Smethurst, E., Mason, S., Blyth, K., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2014.12.002 · Cited by 820 · see citing works
Végran, F., Boidot, R., Michiels, C., Sonveaux, P., & Feron, O. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2828 · Cited by 816 · see citing works
Targeted inhibition of mutant IDH2 in leukemia cells induces cellular differentiation
Wang, F., Travins, J., DeLaBarre, B., Penard-Lacronique, V., Schalm, S., Hansen, E., Straley, K., Kernytsky, A., Liu, W., Gliser, C., et al. (2013) · Science · doi:10.1126/science.1234769 · Cited by 804 · see citing works
Paschka, P., Schlenk, R. F., Gaidzik, V. I., Habdank, M., Krönke, J., Bullinger, L., Späth, D., Käyser, S., Zucknick, M., Götze, K. S. S., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.3762 · Cited by 803 · see citing works
Mitochondrial reactive oxygen species and cancer
Sullivan, L. B., & Chandel, N. S. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-17 · Cited by 799 · see citing works
p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase
Jiang, P., Du, W., Wang, X., Mancuso, A., Gao, X., Wu, M., & Yang, X. (2011) · Nature Cell Biology · doi:10.1038/ncb2172 · Cited by 798 · see citing works
Tan, A. S., Baty, J. W., Dong, L.-F., Bezawork-Geleta, A., Endaya, B., Goodwin, J., Bajzikova, M., Kovarova, J., Peterka, M., Yan, B., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2014.12.003 · Cited by 785 · see citing works
SDH mutations establish a hypermethylator phenotype in paraganglioma
Letouzé, E., Martinelli, C., Loriot, C., Burnichon, N., Abermil, N., Ottolenghi, C., Janin, M., Menara, M., Nguyen, A. T., Benit, P., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.04.018 · Cited by 776 · see citing works
Lysine propionylation and butyrylation are novel post-translational modifications in histones
Chen, Y., Sprung, R., Tang, Y., Ball, H., Sangras, B., Kim, S. C., Falck, J. R., Peng, J., Gu, W., & Zhao, Y. (2007) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m700021-mcp200 · Cited by 764 · see citing works
Acetate is a bioenergetic substrate for human glioblastoma and brain metastases
Mashimo, T., Pichumani, K., Vemireddy, V., Hatanpaa, K. J., Singh, D. K., Sirasanagandla, S., Nannepaga, S., Piccirillo, S. G., Kovacs, Z., Foong, C., et al. (2014) · Cell · doi:10.1016/j.cell.2014.11.025 · Cited by 760 · see citing works
Differential regulation of mTORC1 by leucine and glutamine
Jewell, J. L., Kim, Y. C., Russell, R. C., Yu, F.-X., Park, H. W., Plouffe, S. W., Tagliabracci, V. S., & Guan, K.-L. (2015) · Science · doi:10.1126/science.1259472 · Cited by 757 · see citing works
Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases
Casero, R. A., & Marton, L. J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2243 · Cited by 752 · see citing works
Yanagida, O., Kanai, Y., Chairoungdua, A., Kim, D. K., Segawa, H., Nii, T., Cha, S. H., Matsuo, H., Fukushima, J.-I., Fukasawa, Y., et al. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00384-4 · Cited by 746 · see citing works
Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1
Ben-Sahra, I., Howell, J. J., Asara, J. M., & Manning, B. D. (2013) · Science · doi:10.1126/science.1228792 · Cited by 739 · see citing works
Tumor-derived lactic acid modulates dendritic cell activation and antigen expression
Gottfried, E., Kunz-Schughart, L. A., Ebner, S., Mueller-Klieser, W., Hoves, S., Andreesen, R., Mackensen, A., & Kreutz, M. (2006) · Blood · doi:10.1182/blood-2005-05-1795 · Cited by 729 · see citing works
Borger, D. R., Tanabe, K. K., Fan, K. C., Lopez, H. U., Fantin, V. R., Straley, K. S., Schenkein, D. P., Hezel, A. F., Ancukiewicz, M., Liebman, H. M., et al. (2012) · The Oncologist · doi:10.1634/theoncologist.2011-0386 · Cited by 728 · see citing works
Kamphorst, J. J., Cross, J. R., Fan, J., de Stanchina, E., Mathew, R., White, E. P., Thompson, C. B., & Rabinowitz, J. D. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307237110 · Cited by 726 · see citing works
Self-citationGlutaminolysis Activates Rag-mTORC1 Signaling
Durán, R. V., Oppliger, W., Robitaille, A. M., Heiserich, L., Skendaj, R., Gottlieb, E., & Hall, M. N. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.05.043 · Cited by 723 · see citing works
Rysman, E., Brusselmans, K., Scheys, K., Timmermans, L., Derua, R., Munck, S., Veldhoven, P. P. V., Waltregny, D., Daniëls, V. W., Machiels, J., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3871 · Cited by 723 · see citing works
Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH
Švastová, E., Hulı́ková, A., Rafajová, M., Zat'ovičová, M., Gibadulinová, A., Casini, A., Cecchi, A., Scozzafava, A., Supuran, C. T., Pastorek, J., et al. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.10.043 · Cited by 711 · see citing works
Losman, J.-A., Looper, R. E., Koivunen, P., Lee, S., Schneider, R. K., McMahon, C., Cowley, G. S., Root, D. E., Ebert, B. L., & Kaelin, W. G. (2013) · Science · doi:10.1126/science.1231677 · Cited by 703 · see citing works
Cai, L., Sutter, B. M., Li, B., & Tu, B. P. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.05.004 · Cited by 701 · see citing works
Compartmentalization of Mammalian Folate-Mediated One-Carbon Metabolism
Tibbetts, A. S., & Appling, D. R. (2010) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.012809.104810 · Cited by 692 · see citing works
Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells
Yuneva, M., Zamboni, N., Oefner, P., Sachidanandam, R., & Lazebnik, Y. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200703099 · Cited by 690 · see citing works
Kerr, M. C., & Teasdale, R. D. (2009) · Traffic · doi:10.1111/j.1600-0854.2009.00878.x · Cited by 685 · see citing works
Comerford, S. A., Huang, Z., Du, X., Wang, Y., Cai, L., Witkiewicz, A. K., Walters, H., Tantawy, M. N., Fu, A., Manning, H. C., et al. (2014) · Cell · doi:10.1016/j.cell.2014.11.020 · Cited by 681 · see citing works
Serine is a natural ligand and allosteric activator of pyruvate kinase M2
Chaneton, B., Hillmann, P., Zheng, L., Martin, A. C. L., Maddocks, O. D. K., Chokkathukalam, A., Coyle, J. E., Jankevics, A., Holding, F. P., Vousden, K. H., et al. (2012) · Nature · doi:10.1038/nature11540 · Cited by 661 · see citing works
Intracellular Crotonyl-CoA Stimulates Transcription through p300-Catalyzed Histone Crotonylation
Sabari, B. R., Tang, Z., Huang, H., Yong-Gonzalez, V., Molina, H., Kong, H. E., Dai, L., Shimada, M., Cross, J. R., Zhao, Y., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.02.029 · Cited by 659 · see citing works
The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type
Yuneva, M. O., Fan, T. W. M., Allen, T. D., Higashi, R. M., Ferraris, D. V., Tsukamoto, T., Matés, J. M., Alonso, F. J., Wang, C., Seo, Y., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.12.015 · Cited by 639 · see citing works
Influence of Threonine Metabolism on <i>S</i> -Adenosylmethionine and Histone Methylation
Shyh-Chang, N., Locasale, J. W., Lyssiotis, C. A., Zheng, Y., Teo, R. Y., Ratanasirintrawoot, S., Zhang, J., Onder, T., Unternaehrer, J. J., Zhu, H., et al. (2013) · Science · doi:10.1126/science.1226603 · Cited by 638 · see citing works
A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence
Kaplon, J., Zheng, L., Meissl, K., Chaneton, B., Selivanov, V. A., Mackay, G., van der Burg, S. H., Verdegaal, E. M. E., Cascante, M., Shlomi, T., et al. (2013) · Nature · doi:10.1038/nature12154 · Cited by 633 · see citing works
�ber den Stoffwechsel der Carcinomzelle
Warburg, O. (1924) · Die Naturwissenschaften · doi:10.1007/bf01504608 · Cited by 631 · see citing works
IDH1 and IDH2 mutations in gliomas
Cohen, A. L., Holmen, S. L., & Colman, H. (2013) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-013-0345-4 · Cited by 629 · see citing works
Janeway, K. A., Kim, S. Y., Lodish, M., Nosé, V., Rustin, P., Gaal, J., Dahia, P. L. M., Liegl, B., Ball, E. R., Raygada, M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009199108 · Cited by 628 · see citing works
Copper is required for oncogenic BRAF signalling and tumorigenesis
Brady, D. C., Crowe, M. S., Turski, M. L., Hobbs, G. A., Yao, X.-J., Chaikuad, A., Knapp, S., Xiao, K., Campbell, S. L., Thiele, D. J., et al. (2014) · Nature · doi:10.1038/nature13180 · Cited by 613 · see citing works
Lysine succinylation and lysine malonylation in histones
Xie, Z., Dai, J., Dai, L., Tan, M., Cheng, Z., Wu, Y., Boeke, J. D., & Zhao, Y. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.015875 · Cited by 613 · see citing works
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2010) · Nature · doi:10.1038/nature09132 · Cited by 613 · see citing works
Self-citationConrad, M., & Sato, H. (2011) · Amino Acids · doi:10.1007/s00726-011-0867-5 · Cited by 607 · see citing works
Nilsson, R., Jain, M., Madhusudhan, N., Sheppard, N. G., Strittmatter, L., Kampf, C., Huang, J., Asplund, A., & Mootha, V. K. (2014) · Nature Communications · doi:10.1038/ncomms4128 · Cited by 607 · see citing works
Step-wise methylation of histone H3K9 positions heterochromatin at the nuclear periphery
Towbin, B. D., González-Aguilera, C., Sack, R., Gaidatzis, D., Kalck, V., Meister, P., Askjaer, P., & Gasser, S. M. (2012) · Cell · doi:10.1016/j.cell.2012.06.051 · Cited by 597 · see citing works
Wieman, H. L., Wofford, J. A., & Rathmell, J. C. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-07-0593 · Cited by 593 · see citing works
Guo, J. Y., Karsli-Uzunbas, G., Mathew, R., Aisner, S. C., Kamphorst, J. J., Strohecker, A. M., Chen, G., Price, S., Lu, W., Teng, X., et al. (2013) · Genes & Development · doi:10.1101/gad.219642.113 · Cited by 589 · see citing works
Rathmell, J. C., Fox, C. J., Plas, D. R., Hammerman, P. S., Cinalli, R. M., & Thompson, C. B. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.20.7315-7328.2003 · Cited by 572 · see citing works
Self-citationL‐asparaginase treatment in acute lymphoblastic leukemia: A focus on <i>Erwinia</i> asparaginase
Pieters, R., Hunger, S. P., Boos, J., Rizzari, C., Silverman, L., Baruchel, A., Goekbuget, N., Schrappe, M., & Pui, C. (2011) · Cancer · doi:10.1002/cncr.25489 · Cited by 569 · see citing works
Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation
Lee, J. V., Carrer, A., Shah, S., Snyder, N. W., Wei, S., Venneti, S., Worth, A. J., Yuan, Z.-F., Lim, H.-W., Liu, S., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.06.004 · Cited by 563 · see citing works
Fatty Acid Synthase As a Potential Therapeutic Target in Cancer
Flavin, R., Peluso, S., Nguyen, P. L., & Loda, M. F. (2010) · Future Oncology · doi:10.2217/fon.10.11 · Cited by 545 · see citing works
Noguchi, T., Inoue, H., & Tanaka, T. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67091-7 · Cited by 544 · see citing works
Regulation of tumor pH and the role of carbonic anhydrase 9
Swietach, P., Vaughan-Jones, R. D., & Harris, A. L. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9064-0 · Cited by 539 · see citing works
ATP citrate lyase is an important component of cell growth and transformation
Bauer, D. E., Hatzivassiliou, G., Zhao, F., Andreadis, C., & Thompson, C. B. (2005) · Oncogene · doi:10.1038/sj.onc.1208773 · Cited by 537 · see citing works
Self-citationSonveaux, P., Copetti, T., De Saedeleer, C. J., Végran, F., Verrax, J., Kennedy, K. M., Moon, E. J., Dhup, S., Danhier, P., Frérart, F., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033418 · Cited by 536 · see citing works
Marin-Valencia, I., Yang, C., Mashimo, T., Cho, S., Baek, H., Yang, X.-L., Rajagopalan, K. N., Maddie, M., Vemireddy, V., Zhao, Z., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.05.001 · Cited by 529 · see citing works
Quantitative Phosphoproteomics Reveal mTORC1 Activates de Novo Pyrimidine Synthesis
Robitaille, A. M., Christen, S., Shimobayashi, M., Cornu, M., Fava, L. L., Moes, S., Prescianotto-Baschong, C., Sauer, U., Jenoe, P., & Hall, M. N. (2013) · Science · doi:10.1126/science.1228771 · Cited by 525 · see citing works
Hypoxia Induces Production of L-2-Hydroxyglutarate
Intlekofer, A. M., Dematteo, R. G., Venneti, S., Finley, L. W. S., Lu, C., Judkins, A. R., Rustenburg, A. S., Grinaway, P. B., Chodera, J. D., Cross, J. R., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.06.023 · Cited by 513 · see citing works
Self-citationIDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics
Sasaki, M., Knobbe, C. B., Munger, J. C., Lind, E. F., Brenner, D., Brüstle, A., Harris, I. S., Holmes, R., Wakeham, A., Haight, J., et al. (2012) · Nature · doi:10.1038/nature11323 · Cited by 513 · see citing works
Acidic pH enhances the invasive behavior of human melanoma cells
Mart�nez-Zaguil�n, R., Seftor, E. A., Seftor, R. E. B., Chu, Y.-W., Gillies, R. J., & Hendrix, M. J. C. (1996) · Clinical & Experimental Metastasis · doi:10.1007/bf00121214 · Cited by 507 · see citing works
A FLUORINATED GLUCOSE ANALOG, 2-FLUORO-2-DEOXY-D-GLUCOSE (F-18)
Som, P., Atkins, H. L., Bandoypadhyay, D., Fowler, J. S., MacGregor, R. R., Matsui, K., OSTER, Z. H., Sacker, D. F., Shiue, C., Turner, H., et al. (1980) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-198012000-00045 · Cited by 504 · see citing works
Pyruvate carboxylase is critical for non–small-cell lung cancer proliferation
Sellers, K., Fox, M. P., Bousamra, M., Slone, S. P., Higashi, R. M., Miller, D. M., Wang, Y., Yan, J., Yuneva, M. O., Deshpande, R., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci72873 · Cited by 497 · see citing works
Liu, W., Le, A., Hancock, C., Lane, A. N., Dang, C. V., Fan, T. W.-M., & Phang, J. M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203244109 · Cited by 483 · see citing works
Pyruvate carboxylase is required for glutamine-independent growth of tumor cells
Cheng, T., Sudderth, J., Yang, C., Mullen, A. R., Jin, E. S., Matés, J. M., & DeBerardinis, R. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016627108 · Cited by 475 · see citing works
Rathmell, J. C., Heiden, M. G. V., Harris, M. H., Frauwirth, K. A., & Thompson, C. B. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00066-6 · Cited by 467 · see citing works
Self-citationWnt signaling directs a metabolic program of glycolysis and angiogenesis in colon cancer
Pate, K. T., Stringari, C., Sprowl‐Tanio, S., Wang, K., TeSlaa, T., Hoverter, N. P., McQuade, M. M., Garner, C., Digman, M. A., Teitell, M. A., et al. (2014) · The EMBO Journal · doi:10.15252/embj.201488598 · Cited by 459 · see citing works
The utilization of extracellular proteins as nutrients is suppressed by mTORC1
Palm, W., Park, Y., Wright, K., Pavlova, N. N., Tuveson, D. A., & Thompson, C. B. (2015) · Cell · doi:10.1016/j.cell.2015.06.017 · Cited by 457 · see citing works
Serine Catabolism Regulates Mitochondrial Redox Control during Hypoxia
Ye, J., Fan, J., Venneti, S., Wan, Y.-W., Pawel, B. R., Zhang, J., Finley, L. W. S., Lu, C., Lindsten, T., Cross, J. R., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0250 · Cited by 452 · see citing works
Self-citationDeprez, J., Vertommen, D., Alessi, D. R., Hue, L., & Rider, M. H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.28.17269 · Cited by 447 · see citing works
Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer
Delage, B., Fennell, D. A., Nicholson, L., McNeish, I., Lemoine, N. R., Crook, T., & Szlosarek, P. W. (2010) · International Journal of Cancer · doi:10.1002/ijc.25202 · Cited by 441 · see citing works
Asparagine Plays a Critical Role in Regulating Cellular Adaptation to Glutamine Depletion
Zhang, J., Fan, J., Venneti, S., Cross, J. R., Takagi, T., Bhinder, B., Djaballah, H., Kanai, M., Cheng, E. H., Judkins, A. R., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.08.018 · Cited by 439 · see citing works
Self-citationStrohecker, A. M., Guo, J. Y., Karsli-Uzunbas, G., Price, S. M., Chen, G. J., Mathew, R., McMahon, M., & White, E. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0397 · Cited by 435 · see citing works
MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis
Terunuma, A., Putluri, N., Mishra, P., Mathé, E. A., Dorsey, T. H., Yi, M., Wallace, T. A., Issaq, H. J., Zhou, M., Killian, J. K., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71180 · Cited by 428 · see citing works
Conserved Metabolic Regulatory Functions of Sirtuins
Schwer, B., & Verdin, E. M. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.11.006 · Cited by 415 · see citing works
Minor, E. A., Court, B. L., Young, J. I., & Wang, G. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.c113.464800 · Cited by 413 · see citing works
Ye, J., Mancuso, A., Tong, X., Ward, P. S., Fan, J., Rabinowitz, J. D., & Thompson, C. B. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1204176109 · Cited by 410 · see citing works
Self-citationATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer
Migita, T., Narita, T., Nomura, K., Miyagi, E., Inazuka, F., Matsuura, M., Ushijima, M., Mashima, T., Seimiya, H., Satoh, Y., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1235 · Cited by 403 · see citing works
The x cystine/glutamate antiporter: A potential target for therapy of cancer and other diseases
Lo, M., Wang, Y., & Gout, P. W. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21366 · Cited by 399 · see citing works
Many roads lead to oncogene-induced senescence
Courtois-Cox, S., Jones, S. L., & Cichowski, K. (2008) · Oncogene · doi:10.1038/sj.onc.1210950 · Cited by 397 · see citing works
The identification of ATP-citrate lyase as a protein kinase B (Akt) substrate in primary adipocytes
Berwick, D. C., Hers, I., Heesom, K. J., Moule, S. K., & Tavareá, J. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204681200 · Cited by 383 · see citing works
Wellen, K. E., Lu, C., Mancuso, A., Lemons, J. M. S., Ryczko, M., Dennis, J. W., Rabinowitz, J. D., Coller, H. A., & Thompson, C. B. (2010) · Genes & Development · doi:10.1101/gad.1985910 · Cited by 377 · see citing works
Self-citation18 F-FDG PET/CT Imaging In Oncology
Almuhaideb, A., Papathanasiou, N. D., & Bomanji, J. B. (2011) · Annals of Saudi Medicine · doi:10.4103/0256-4947.75771 · Cited by 377 · see citing works
Oldham, W. M., Clish, C. B., Yang, Y., & Loscalzo, J. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.06.021 · Cited by 364 · see citing works
MacKenzie, E. D., Selak, M. A., Tennant, D. A., Payne, L. J., Crosby, S., Frederiksen, C. M., Watson, D. G., & Gottlieb, E. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01927-06 · Cited by 359 · see citing works
Lactate enhances motility of tumor cells and inhibits monocyte migration and cytokine release
Goetze, K. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1055 · Cited by 356 · see citing works
Killian, J. K., Kim, S. Y., Miettinen, M., Smith, C., Merino, M., Tsokos, M., Quezado, M., Smith, W. I., Jahromi, M. S., Xekouki, P., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0092 · Cited by 356 · see citing works
Acetyl-CoA Carboxylase α Is Essential to Breast Cancer Cell Survival
Chajès, V., Cambot, M., Moreau, K., Lenoir, G. M., & Joulin, V. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1489 · Cited by 347 · see citing works
Metabolism of [U‐ <sup>13</sup> C]glucose in human brain tumors <i>in vivo</i>
Maher, E. A., Marin‐Valencia, I., Bachoo, R. M., Mashimo, T., Raisanen, J., Hatanpaa, K. J., Jindal, A., Jeffrey, F. M., Choi, C., Madden, C., et al. (2012) · NMR in Biomedicine · doi:10.1002/nbm.2794 · Cited by 341 · see citing works
Enzymes of the fatty acid synthesis pathway are highly expressed in in situ breast carcinoma.
Milgraum, L. Z., Witters, L. A., Pasternack, G. R., & Kuhajda, F. P. (1997) · PubMed · Cited by 333 · see citing works
Niculescu, M. D., Craciunescu, C. N., & Zeisel, S. H. (2006) · The FASEB Journal · doi:10.1096/fj.05-4707com · Cited by 330 · see citing works
Regulation of GLUT1 Gene Transcription by the Serine/Threonine Kinase Akt1
Barthel, A., Okino, S. T., Liao, J., Nakatani, K., Li, J., Whitlock, J. P., & Roth, R. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.29.20281 · Cited by 328 · see citing works
Trial watch: IDO inhibitors in cancer therapy
Vacchelli, E., Aranda, F., Eggermont, A. M. M., Sautès‐Fridman, C., Tartour, É., Kennedy, E. P., Platten, M., Zitvogel, L., Kroemer, G., & Galluzzi, L. (2014) · OncoImmunology · doi:10.4161/21624011.2014.957994 · Cited by 327 · see citing works
Eagle, H. (1955) · The Journal of Experimental Medicine · doi:10.1084/jem.102.5.595 · Cited by 323 · see citing works
L-asparaginase therapy for leukemia and other malignant neoplasms. Remission in human leukemia
Hill, J. M. (1967) · JAMA · doi:10.1001/jama.202.9.882 · Cited by 322 · see citing works
Global Regulation of Nucleotide Biosynthetic Genes by c-Myc
Liu, Y.-C., Li, F., Handler, J., Huang, C. R. L., Xiang, Y., Neretti, N., Sedivy, J. M., Zeller, K. I., & Dang, C. V. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002722 · Cited by 317 · see citing works
Ensor, M., Holtsberg, F. W., Bomalaski, J. S., & Clark, M. A. (2002) · PubMed · Cited by 315 · see citing works
Connecting threads: epigenetics and metabolism
Katada, S., Imhof, A., & Sassone-Corsi, P. (2012) · Cell · doi:10.1016/j.cell.2012.01.001 · Cited by 315 · see citing works
Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo
Venneti, S., Dunphy, M. P., Zhang, H., Pitter, K. L., Zanzonico, P., Campos, C., Carlin, S., Rocca, G. L., Lyashchenko, S. K., Plöessl, K., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa1009 · Cited by 314 · see citing works
Self-citationPlas, D. R., Talapatra, S., Edinger, A. L., Rathmell, J. C., & Thompson, C. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010551200 · Cited by 308 · see citing works
Self-citationItkonen, H. M., Minner, S. J. P., Guldvik, I. J., Sandmann, M. J., Tsourlakis, M. C., Berge, V., Svindland, A., Schlomm, T., & Mills, I. G. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0549 · Cited by 293 · see citing works
Lipoprotein lipase links dietary fat to solid tumor cell proliferation
Kuemmerle, N. B., Rysman, E., Lombardo, P. S., Flanagan, A. J., Lipe, B. C., Wells, W. A., Pettus, J. R., Froehlich, H. M., Memoli, V. A., Morganelli, P. M., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0802 · Cited by 286 · see citing works
Donald, S. P., Sun, X. Y., Hu, C.-A. A., Yu, J., Mei, J. M., Valle, D. L., & Phang, J. M. (2001) · PubMed · Cited by 283 · see citing works
<scp>l</scp> -2-Hydroxyglutarate: An Epigenetic Modifier and Putative Oncometabolite in Renal Cancer
Shim, E.-H., Livi, C. B., Rakheja, D., Tan, J., Benson, D., Parekh, V., Kho, E.-Y., Ghosh, A. P., Kirkman, R., Velu, S., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0696 · Cited by 280 · see citing works
Kung, H.-N., Marks, J. R., & Chi, J.-T. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002229 · Cited by 277 · see citing works
Cunningham, J. T., Moreno, M. V., Lodi, A., Ronen, S. M., & Ruggero, D. (2014) · Cell · doi:10.1016/j.cell.2014.03.052 · Cited by 260 · see citing works
Direct role of nucleotide metabolism in C-MYC-dependent proliferation of melanoma cells
Mannava, S., Grachtchouk, V., Wheeler, L. J., Im, M., Zhuang, D., Slavina, E. G., Mathews, C. K., Shewach, D. S., & Nikiforov, M. A. (2008) · Cell Cycle · doi:10.4161/cc.6390 · Cited by 257 · see citing works
The metabolism of proline, a stress substrate, modulates carcinogenic pathways
Phang, J. M., Donald, S. P., Pandhare, J., & Liu, Y. (2008) · Amino Acids · doi:10.1007/s00726-008-0063-4 · Cited by 252 · see citing works
Glutamine metabolism is essential for human cytomegalovirus infection
Chambers, J. W., Maguire, T. G., & Alwine, J. C. (2010) · Journal of Virology · doi:10.1128/jvi.02123-09 · Cited by 238 · see citing works
Competition between human cells by entosis
Sun, Q., Luo, T., Ren, Y., Florey, O., Shirasawa, S., Sasazuki, T., Robinson, D. N., & Overholtzer, M. (2014) · Cell Research · doi:10.1038/cr.2014.138 · Cited by 233 · see citing works
Regulation of carbamoyl phosphate synthetase by MAP kinase
Graves, L. M., Guy, H. I., Kozlowski, P., Huang, M., Lazarowski, E. R., Pope, R. M., Collins, M. A., Dahlstrand, E. N., Earp, H. S., & Evans, D. R. (2000) · Nature · doi:10.1038/35002111 · Cited by 232 · see citing works
Keller, K. E., Tan, I. S., & Lee, Y.-S. (2012) · Science · doi:10.1126/science.1224409 · Cited by 228 · see citing works
FAD-dependent lysine-specific demethylase-1 regulates cellular energy expenditure
Hino, S., Sakamoto, A., Nagaoka, K., Anan, K., Wang, Y., Mimasu, S., Umehara, T., Yokoyama, S., Kosai, K.-I., & Nakao, M. (2012) · Nature Communications · doi:10.1038/ncomms1755 · Cited by 226 · see citing works
Hydrogen sulfide in cancer: Friend or foe?
Wu, D., Si, W., Wang, M.-J., Lv, S., Ji, A., & Li, Y. (2015) · Nitric Oxide · doi:10.1016/j.niox.2015.08.004 · Cited by 217 · see citing works
Control of glutamine metabolism by the tumor suppressor Rb
Reynolds, M. R., Lane, A. N., Robertson, B., Kemp, S., Liu, Y., Hill, B. G., Dean, D. C., & Clem, B. F. (2014) · Oncogene · doi:10.1038/onc.2012.635 · Cited by 216 · see citing works
Lactate Stimulates Fibroblast Expression of Hyaluronan and CD44: The Warburg Effect Revisited
Stern, R., Shuster, S., Neudecker, B. A., & Formby, B. (2002) · Experimental Cell Research · doi:10.1006/excr.2002.5508 · Cited by 216 · see citing works
c-Myc Mediates Activation of the cad Promoter via a Post-RNA Polymerase II Recruitment Mechanism
Eberhardy, S. R., & Farnham, P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m109014200 · Cited by 215 · see citing works
Young, R. M., Ackerman, D., Quinn, Z. L., Mancuso, A., Gruber, M., Liu, L., Giannoukos, D. N., Bobrovnikova-Marjon, E. V., Diehl, J. A., Keith, B., et al. (2013) · Genes & Development · doi:10.1101/gad.198630.112 · Cited by 214 · see citing works
Direct Visualization of De novo Lipogenesis in Single Living Cells
Li, J., & Cheng, J. (2014) · Scientific Reports · doi:10.1038/srep06807 · Cited by 183 · see citing works
PET Imaging of Glutaminolysis in Tumors by 18 F-( 2S,4R )4-Fluoroglutamine
Lieberman, B. P., Plöessl, K., Wang, L., Qü, W., Zha, Z., Wise, D. R., Chodosh, L. A., Belka, G. K., Thompson, C. B., & Kung, H. F. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.093815 · Cited by 176 · see citing works
Self-citationImpact of MYC in regulation of tumor cell metabolism
Wahlström, T., & Arsenian‐Henriksson, M. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.07.004 · Cited by 176 · see citing works
Mehedint, M. G., Niculescu, M. D., Craciunescu, C. N., & Zeisel, S. H. (2010) · The FASEB Journal · doi:10.1096/fj.09-140145 · Cited by 167 · see citing works
Yoon, C., Shim, Y., Kim, E., Lee, J., Won, N., Kim, J., Park, I., Yoon, D., & Min, B. (2007) · International Journal of Cancer · doi:10.1002/ijc.22322 · Cited by 165 · see citing works
Gaglio, D., Soldati, C., Vanoni, M., Alberghina, L., & Chiaradonna, F. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004715 · Cited by 164 · see citing works
Wiśniewski, J. R., Zougman, A., & Mann, M. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkm1057 · Cited by 163 · see citing works
Constant, J. S., Feng, J. J., Zabel, D. D., Yuan, H., Suh, D. Y., Scheuenstuhl, H., Hunt, T. K., & Hussain, M. Z. (2000) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2000.00353.x · Cited by 163 · see citing works
Induction of sarcomas by mutant IDH2Preprint
Lü, C., Venneti, S., Akalin, A., Fang, F., Ward, P. S., Dematteo, R. G., Intlekofer, A. M., Chen, C., Ye, J., Hameed, M., et al. (2013) · Genes & Development · doi:10.1101/gad.226753.113 · Cited by 157 · see citing works
Self-citationDiminished tumorigenic phenotype after depletion of mitochondrial DNA.
Cavalli, L. R., Varella‐Garcia, M., & Liang, B. C. (1997) · PubMed · Cited by 154 · see citing works
Bowles, T. L., Kim, R., Galante, J., Parsons, C. M., Virudachalam, S., Kung, H., & Bold, R. J. (2008) · International Journal of Cancer · doi:10.1002/ijc.23723 · Cited by 153 · see citing works
Amino acid, glucose, and lactic acid utilization in vivo by rat tumors.
Sauer, L. A., Stayman, J. W., & Dauchy, R. T. (1982) · PubMed · Cited by 152 · see citing works
mTOR regulates phagosome and entotic vacuole fission
Krajcovic, M., Krishna, S., Akkari, L., Joyce, J. A., & Overholtzer, M. (2013) · Molecular Biology of the Cell · doi:10.1091/mbc.e13-07-0408 · Cited by 149 · see citing works
Flagged first, then by citations
12 of the 254 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Metabolic regulation of gene expression by histone lactylation
Zhang, D., Tang, Z., Huang, H., Zhou, G., Cui, C., Weng, Y., Liu, W., Kim, S., Lee, S., Perez-Neut, M., et al. (2019) · Nature · doi:10.1038/s41586-019-1678-1 · Cited by 4,371 · see citing works
A pathology atlas of the human cancer transcriptome
Uhlen, M., Zhang, C., Lee, S., Sjöstedt, E., Fagerberg, L., Bidkhori, G., Benfeitas, R., Arif, M., Liu, Z., Edfors, F., et al. (2017) · Science · doi:10.1126/science.aan2507 · Cited by 3,371 · see citing works
Fundamentals of Cancer Metabolism
DeBerardinis, R. J., & Chandel, N. S. (2016) · Science Advances · doi:10.1126/sciadv.1600200 · Cited by 3,013 · see citing works
“Because some altered metabolic features are observed quite generally across many types of cancer cells, reprogrammed metabolism is considered a hallmark of cancer (1, 2).”
BackgroundMetabolic reprogramming and cancer progression
Faubert, B., Solmonson, A., & DeBerardinis, R. J. (2020) · Science · doi:10.1126/science.aaw5473 · Cited by 2,740 · see citing works
“A central concept in cancer metabolism is that malignant cells acquire an enhanced ability to feed themselves by activating nutrient uptake mechanisms (33).”
BackgroundCystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy
Koppula, P., Zhuang, L., & Gan, B. (2020) · Protein & Cell · doi:10.1007/s13238-020-00789-5 · Cited by 2,546 · see citing works
NF-κB in biology and targeted therapy: new insights and translational implications
Guo, Q., Jin, Y., Chen, X., Ye, X., Shen, X., Lin, M., Zeng, C., Zhou, T., & Zhang, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01757-9 · Cited by 2,267 · see citing works
“The emerging role of metabolic reprogramming has been demonstrated in the tumor progression, 285 featuring high demand for nitrogen and deregulated mitochondrial oxidative phosphorylation.”
BackgroundVyas, S., Zaganjor, E., & Haigis, M. C. (2016) · Cell · doi:10.1016/j.cell.2016.07.002 · Cited by 1,735 · see citing works
Zielonka, J., Joseph, J., Sikora, A., Hardy, M., Ouari, O., Vasquez-Vivar, J., Cheng, G., Lopez, M., & Kalyanaraman, B. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00042 · Cited by 1,683 · see citing works
Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics
Puchalska, P., & Crawford, P. A. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.12.022 · Cited by 1,617 · see citing works
“Cancer cells undergo metabolic reprogramming to maintain rapid cell proliferation and growth (DeNicola and Cantley, 2015; Pavlova and Thompson, 2016).”
BackgroundThe hallmarks of cancer metabolism: still emerging
Pavlova, N. N., Zhu, J., & Thompson, C. B. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.01.007 · Cited by 1,418 · see citing works
Self-citationEndoplasmic reticulum stress signals in the tumour and its microenvironment
Chen, X., & Cubillos-Ruiz, J. R. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-020-00312-2 · Cited by 1,356 · see citing works
Mitochondrial metabolism and cancer
Porporato, P. E., Filigheddu, N., Pedro, J. M. B., Kroemer, G., & Galluzzi, L. (2017) · Cell Research · doi:10.1038/cr.2017.155 · Cited by 1,292 · see citing works
“, ATP citrate lyase (ACLY), is required for cancer cells to proliferate at optimal rates [85], but not for normal cells to do so (owing to a glucose-to-acetate metabolic switch) [86].”
BackgroundThe Acidic Tumor Microenvironment as a Driver of Cancer
Boedtkjer, E., & Pedersen, S. F. (2019) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021119-034627 · Cited by 1,248 · see citing works
Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion
Leone, R. D., Zhao, L., Englert, J. M., Sun, I.-M., Oh, M.-H., Sun, I.-H., Arwood, M. L., Bettencourt, I. A., Patel, C. H., Wen, J., et al. (2019) · Science · doi:10.1126/science.aav2588 · Cited by 1,169 · see citing works
mTOR signalling and cellular metabolism are mutual determinants in cancer
Mossmann, D., Park, S., & Hall, M. N. (2018) · Nature reviews. Cancer · doi:10.1038/s41568-018-0074-8 · Cited by 1,088 · see citing works
Metabolic regulation of gene expression through histone acylations
Sabari, B. R., Zhang, D., Allis, C. D., & Zhao, Y. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.140 · Cited by 1,134 · see citing works
Metabolic regulation of cell growth and proliferation
Zhu, J., & Thompson, C. B. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0123-5 · Cited by 1,106 · see citing works
Self-citationTargeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy
Bader, J. E., Voss, K., & Rathmell, J. C. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.05.034 · Cited by 1,038 · see citing works
BAP1 links metabolic regulation of ferroptosis to tumour suppression
Zhang, Y., Shi, J., Liu, X., Li, F., Gong, Z., Koppula, P., Sirohi, K., Li, X., Wei, Y., Lee, H., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0178-0 · Cited by 1,024 · see citing works
CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer
Zhang, H., Deng, T., Liu, R., Ning, T., Yang, H., Liu, D., Zhang, Q., Lin, D., Ge, S., Bai, M., et al. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01168-8 · Cited by 1,023 · see citing works
Targeting Metabolism for Cancer Therapy
Luengo, A., Gui, D. Y., & Vander Heiden, M. G. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.08.028 · Cited by 971 · see citing works
“Proliferating cells have different metabolic requirements from non-proliferating cells (Hsu and Sabatini, 2008; Lunt and Vander Heiden, 2011; Pavlova and Thompson, 2016).”
BackgroundLactate in the Regulation of Tumor Microenvironment and Therapeutic Approaches
de la Cruz-López, K. G., Castro-Muñoz, L. J., Reyes-Hernández, D. O., García-Carrancá, A., & Manzo-Merino, J. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01143 · Cited by 940 · see citing works
Yi, J.-M., Zhu, J., Wu, J., Thompson, C. B., & Jiang, X. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2017152117 · Cited by 982 · see citing works
“Cancer cells usually endure elevated oxidative stress due to increased metabolic and proliferative burden (42, 43).”
BackgroundSelf-citationTurning Cold into Hot: Firing up the Tumor Microenvironment
Duan, Q., Zhang, H., Zheng, J., & Zhang, L. (2020) · Trends in Cancer · doi:10.1016/j.trecan.2020.02.022 · Cited by 934 · see citing works
Koppula, P., Zhang, Y., Zhuang, L., & Gan, B. (2018) · 癌症:英文版 · doi:10.1186/s40880-018-0288-x · Cited by 932 · see citing works
“One common mechanism employed by cancer cells for metabolic reprogramming is to increase uptake of nutrients critical for biosynthetic and bioenergetic processes in cancer cells, including glucose and amino acids such as glutamine [5, 6].”
BackgroundMetabolic Interactions in the Tumor Microenvironment
Lyssiotis, C. A., & Kimmelman, A. C. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.06.003 · Cited by 853 · see citing works
Vaupel, P. W., Schmidberger, H., & Mayer, A. (2019) · International Journal of Radiation Biology · doi:10.1080/09553002.2019.1589653 · Cited by 901 · see citing works
“Furthermore, it can lead to radioresistance, impedes antitumor immunity, diminishes the effectiveness of basic chemotherapeutic drugs and may contribute to drug resistance via mTOR-signaling (Pavlova and Thompson 2016; Corbet and Feron 2017).”
BackgroundGlutaminolysis: A Hallmark of Cancer Metabolism
Yang, L., Venneti, S., & Nagrath, D. (2017) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071516-044546 · Cited by 859 · see citing works
“In order to systematically understand the role of metabolic reprogramming in cancer cells on establishing and maintaining a tumorigenic status, Pavlova & Thompson (2) summarized”
BackgroundThe role of m6A RNA methylation in cancer metabolism
An, Y., & Duan, H. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01500-4 · Cited by 892 · see citing works
“In order to survive and adapt to these severe environmental pressures, cancer cells change their metabolic pathways to capture external metabolites and maximize the efficiency of metabolic enzymes [12].”
BackgroundRevisiting the hallmarks of cancer.
Fouad, Y. A., & Aanei, C. M. (2017) · Europe PMC (PubMed Central) · Cited by 873 · see citing works
Wang, Q., Chen, C., Ding, Q., Zhao, Y. Q., Wang, Z., Chen, J., Jiang, Z., Zhang, Y., Xu, G., Zhang, J., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-319639 · Cited by 861 · see citing works
Autophagy and Tumor Metabolism
Kimmelman, A. C., & White, E. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.04.004 · Cited by 826 · see citing works
“…A uthor M anuscript A uthor M anuscript A uthor M anuscript Metabolism and Cancer It has long been known that cancers have altered metabolism to help meet the needs of cells that have the potential for unconstrained proliferation (Pavlova and Thompson, 2016; Vander Heiden and DeBerardinis, 2017).”
BackgroundExtrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity
Turner, K. M., Deshpande, V., Beyter, D., Koga, T., Rusert, J. M., Lee, C., Li, B., Arden, K. C., Ren, B., Nathanson, D. A., et al. (2017) · Nature · doi:10.1038/nature21356 · Cited by 852 · see citing works
Mitochondria as a therapeutic target for common pathologies
Murphy, M. P., & Hartley, R. C. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.174 · Cited by 832 · see citing works
Glutamine Metabolism in Cancer: Understanding the Heterogeneity
Cluntun, A. A., Lukey, M. J., Cerione, R. A., & Locasale, J. W. (2017) · Trends in Cancer · doi:10.1016/j.trecan.2017.01.005 · Cited by 796 · see citing works
“Glutamine serves as an important source of reduced nitrogen for biosynthetic reactions, and as a source of carbon to replenish the tricarboxylic acid (TCA) cycle, produce glutathione, and serve as a precursor to nucleotide and lipid synthesis via reductive carboxylation (Figure 1) [1,2,6,7].”
Mutant p53 as a guardian of the cancer cell
Mantovani, F., Collavin, L., & Sal, G. D. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0246-9 · Cited by 780 · see citing works
“tumor growth in hypoxic conditions and contributes to suppress immune surveillance through extracellular acidification [33].”
Metabolic Flexibility as an Adaptation to Energy Resources and Requirements in Health and Disease
Smith, R. L., Soeters, M. R., Wüst, R. C. I., & Houtkooper, R. H. (2018) · Endocrine Reviews · doi:10.1210/er.2017-00211 · Cited by 787 · see citing works
Metabolic reprogramming and epigenetic modifications on the path to cancer
Sun, L., Zhang, H., & Gao, P. (2021) · Protein & Cell · doi:10.1007/s13238-021-00846-7 · Cited by 796 · see citing works
“Metabolic reprogramming is one of the major features of cancer, during which characteristics of metabolic enzymes, upstream regulating molecules and downstream metabolic products, known as metabolites, are altered (DeBerardinis et al., 2008b; Heiden et al., 2009; Jones and Thompson, 2009; Hanahan and Weinberg, 2011; D…”
BackgroundObesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor Immunity
Ringel, A. E., Drijvers, J. M., Baker, G. J., Catozzi, A., García-Cañaveras, J. C., Gassaway, B. M., Miller, B. C., Juneja, V. R., Nguyen, T. H., Joshi, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.11.009 · Cited by 780 · see citing works
“A hallmark feature of tumor cell metabolism is increased nutrient consumption tomeet energetic, anabolic, and pro-survival demands (Pavlova and Thompson, 2016; Spinelli and Haigis, 2018).”
BackgroundROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway
Zhao, Y., Hu, X., Liu, Y., Dong, S., Wen, Z., He, W., Zhang, S., Huang, Q., & Shi, M. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0648-1 · Cited by 735 · see citing works
“Further, B Chaube et al. found that AMPK could enhance mitochondrial biogenesis and OXPHOS by activating p38/PGC1α pathway [53].”
InfluentialChen, F., Chen, J., Yang, L., Liu, J., Zhang, X., Zhang, Y., Tu, Q., Yin, D., Lin, D., Wong, P., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0299-0 · Cited by 712 · see citing works
LncRNA‐mediated posttranslational modifications and reprogramming of energy metabolism in cancer
Tan, Y., Lin, J., Li, T., Li, J., Xu, R., & Ju, H. (2020) · 癌症:英文版 · doi:10.1002/cac2.12108 · Cited by 705 · see citing works
Cancer cell metabolism: the essential role of the nonessential amino acid, glutamine
Zhang, J., Pavlova, N. N., & Thompson, C. B. (2017) · The EMBO Journal · doi:10.15252/embj.201696151 · Cited by 651 · see citing works
“Thus, levels of certain metabolites are continuously monitored by a cell, directly informing cellular decisions on gene expression, affecting cellular differentiation as a result (Pavlova & Thompson, 2016).”
Self-citationCold and hot tumors: from molecular mechanisms to targeted therapy
Wu, B., Zhang, B., Li, B., Wu, H., & Jiang, M. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01979-x · Cited by 751 · see citing works
Metabolites and the Tumour Microenvironment: From Cellular Mechanisms to Systemic Metabolism
Elia, I., & Haigis, M. C. (2021) · Nature Metabolism · doi:10.1038/s42255-020-00317-z · Cited by 651 · see citing works
Metabolomics in cancer research and emerging applications in clinical oncology
Schmidt, D. R., Patel, R., Kirsch, D. G., Lewis, C. A., Heiden, M. G. V., & Locasale, J. W. (2021) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21670 · Cited by 652 · see citing works
Vascular heterogeneity and specialization in development and disease
Potente, M., & Mäkinen, T. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.36 · Cited by 653 · see citing works
Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma
Du, D., Liu, C., Qin, M., Zhang, X., Xi, T., Yuan, S., Hao, H., & Xiong, J. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.09.019 · Cited by 649 · see citing works
Lactate Is a Natural Suppressor of RLR Signaling by Targeting MAVS
Zhang, W., Wang, G., Xu, Z., Tu, H.-Q., Hu, F., Dai, J., Chang, Y., Chen, Y., Lu, Y., Zeng, H., et al. (2019) · Cell · doi:10.1016/j.cell.2019.05.003 · Cited by 598 · see citing works
“, 2013), exposed to hypoxia microenvironment and favored glycolysis for energy metabolism known as Warburg effect (Nakazawa et al., 2016; Pavlova and Thompson, 2016), it is likely that limiting type-I IFN production by these conditions through generating more lactate may serve as another important mechanism for cancer…”
BackgroundMetabolic barriers to cancer immunotherapy
DePeaux, K., & Delgoffe, G. M. (2021) · Nature reviews. Immunology · doi:10.1038/s41577-021-00541-y · Cited by 614 · see citing works
Liu, X., Olszewski, K. L., Zhang, Y., Lim, E. W., Shi, J., Zhang, X., Zhang, J., Lee, H., Koppula, P., Lei, G., et al. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-0496-x · Cited by 599 · see citing works
Metabolic landscape of the tumor microenvironment at single cell resolution
Xiao, Z., Dai, Z., & Locasale, J. W. (2019) · Nature Communications · doi:10.1038/s41467-019-11738-0 · Cited by 524 · see citing works
A New View into the Regulation of Purine Metabolism: The Purinosome
Pedley, A. M., & Benkovic, S. J. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.09.009 · Cited by 580 · see citing works
“A recent framework explains the role of altered cellular metabolism in tumorigenesis and outlines the bioenergetics and biomolecular needs of cancer cells [67].”
Spatial maps of prostate cancer transcriptomes reveal an unexplored landscape of heterogeneity
Berglund, E., Maaskola, J., Schultz, N., Friedrich, S., Marklund, M., Bergenstråhle, J., Tarish, F., Tanoglidi, A., Vicković, S., Larsson, L., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04724-5 · Cited by 550 · see citing works
Methionine metabolism in health and cancer: a nexus of diet and precision medicine
Sanderson, S. M., Gao, X., Dai, Z., & Locasale, J. W. (2019) · Nature reviews. Cancer · doi:10.1038/s41568-019-0187-8 · Cited by 572 · see citing works
The emerging role and targetability of the TCA cycle in cancer metabolism
Anderson, N. M., Mucka, P., Kern, J. G., & Feng, H. (2017) · Protein & Cell · doi:10.1007/s13238-017-0451-1 · Cited by 558 · see citing works
“Indeed, various types of cancer cells increase their glucose uptake and preferentially utilize glucose through aerobic glycolysis (Gillies and Gatenby, 2007; Pavlova and Thompson, 2016).”
BackgroundCancer Metabolism: Phenotype, Signaling and Therapeutic Targets
Park, J. H., Pyun, W. Y., & Park, H. W. (2020) · Cells · doi:10.3390/cells9102308 · Cited by 558 · see citing works
“To survive and adapt to these harsh environmental stresses, cancer cells modify their metabolic pathways to capture external metabolites and maximize the efficiency of metabolic enzyme activities [9].”
BackgroundNavigating CAR-T cells through the solid-tumour microenvironment
Hou, A. J., Chen, L. C., & Chen, Y. Y. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00189-2 · Cited by 556 · see citing works
Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancerPreprint
Gimple, R. C., Bhargava, S., Dixit, D., & Rich, J. N. (2019) · Genes & Development · doi:10.1101/gad.324301.119 · Cited by 539 · see citing works
“…& DEVELOPMENT 597 GSC metabolism: fueling tumor growth The metabolic dysregulation of cancer cells has been well documented for centuries and has served as an integral component of our understanding of cancer initiation, growth, and adaptation (Hanahan and Weinberg 2011; Pavlova and Thompson 2016).”
BackgroundThe impact of cellular metabolism on chromatin dynamics and epigenetics
Reid, M. A., Dai, Z., & Locasale, J. W. (2017) · Nature Cell Biology · doi:10.1038/ncb3629 · Cited by 515 · see citing works
Wang, M., Mao, C., Ouyang, L., Liu, Y., Lai, W., Liu, N., Shi, Y., Chen, L., Xiao, D., Yu, F., et al. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0304-y · Cited by 530 · see citing works
Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy
Krug, K., Jaehnig, E. J., Satpathy, S., Blumenberg, L. M., Karpova, A. Y., Anurag, M., Miles, G., Mertins, P., Geffen, Y., Tang, L. C., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.036 · Cited by 532 · see citing works
“Proteogenomic Metabolic Profiling and Acetylproteomics Highlight Subtype-Specific Metabolism Therapeutic targeting of abnormal cancer metabolism is garnering increased attention (Pavlova and Thompson, 2016; Phan et al., 2014).”
BackgroundFatty acid oxidation: An emerging facet of metabolic transformation in cancer
Ma, Y., Temkin, S. M., Hawkridge, A. M., Guo, C., Wang, W., Wang, X., & Fang, X. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.08.006 · Cited by 541 · see citing works
Viral hijacking of cellular metabolism
Thaker, S. K., Ch’ng, J., & Christofk, H. R. (2019) · BMC Biology · doi:10.1186/s12915-019-0678-9 · Cited by 518 · see citing works
The landscape of cancer cell line metabolism
Li, H., Ning, S., Ghandi, M., Kryukov, G. V., Gopal, S., Deik, A., Souza, A., Pierce, K. A., Keskula, P., Hernandez, D., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0404-8 · Cited by 511 · see citing works
Overcoming cancer therapeutic bottleneck by drug repurposing
Zhang, Z., Zhou, L., Xie, N., Nice, E. C., Zhang, T., Cui, Y., & Huang, C. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00213-8 · Cited by 521 · see citing works
“Reprogramming energy metabolism is ubiquitous in cancer cells, and primarily supports malignancy by sustaining key hallmarks of cancer, including uncontrolled cell proliferation, evading growth suppressors, and resisting cell death.(37,149) Cancer cells exhibit anomalous energy metabolism, termed aerobic glycolysis, w…”
BackgroundAltered metabolism in cancer: insights into energy pathways and therapeutic targets
Tufail, M., Jiang, C.-H., & Li, N. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02119-3 · Cited by 534 · see citing works
“The balance between oncogenes and tumor suppressors determines the metabolic phenotype of a cell [152].”
BackgroundAdipocyte-induced CD36 expression drives ovarian cancer progression and metastasis
Ladányi, A., Mukherjee, A., Kenny, H. A., Johnson, A., Mitra, A. K., Sundaresan, S., Nieman, K. M., Pascual, G., Benitah, S. A., MONTAG, A. G., et al. (2018) · Oncogene · doi:10.1038/s41388-017-0093-z · Cited by 522 · see citing works
“A recently described hallmark of cancer metabolism is the ability of cancer cells to acquire nutrients from the tumour microenvironment [40].”
Molecular mechanisms of tumor resistance to radiotherapy
Wu, Y., Song, Y., Wang, R., & Wang, T. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01801-2 · Cited by 539 · see citing works
Metabolism, metabolites, and macrophages in cancer
Li, M., Yang, Y., Xiong, L., Jiang, P., Wang, J., & Li, C. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01478-6 · Cited by 518 · see citing works
“Nevertheless, studies have shown that high glycolytic rates can provide metabolic precursors for biomass production [44, 45].”
BackgroundYang, E., Wang, X., Gong, Z., Yu, M., Wu, H., & Zhang, D. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00359-5 · Cited by 502 · see citing works
“Therefore, metabolic reprogramming is regarded as one of the hallmarks of cancer.(1,2) The abnormal metabolic functions of cancer cells were first proposed by Otto Warburg, who discovered that cancer cells consumed more glucose relative to normal cells.”
BackgroundThe evolving metabolic landscape of chromatin biology and epigenetics
Dai, Z., Ramesh, V., & Locasale, J. W. (2020) · Nature Reviews Genetics · doi:10.1038/s41576-020-0270-8 · Cited by 493 · see citing works
Mitochondrial Sirtuin 3: New emerging biological function and therapeutic target
Zhang, J., Xiang, H., Liu, J., Chen, Y., He, R.-R., & Liu, B. (2020) · Theranostics · doi:10.7150/thno.45922 · Cited by 503 · see citing works
Interplay between Circadian Clock and Cancer: New Frontiers for Cancer Treatment
Sulli, G., Lam, M. T. Y., & Panda, S. (2019) · Trends in cancer · doi:10.1016/j.trecan.2019.07.002 · Cited by 484 · see citing works
Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics
Jin, H.-R., Wang, J., Wang, Z., Xi, M., Xia, B., Deng, K., & Yang, J. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01498-2 · Cited by 509 · see citing works
Yen, K., Travins, J., Wang, F., David, M. D., Artin, E., Straley, K., Padyana, A., Gross, S., DeLaBarre, B., Tobin, E., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-1034 · Cited by 471 · see citing works
“Metabolic reprogramming is a hallmark of cancer, contributing to the initiation and maintenance of tumors (1, 2).”
BackgroundLipids in the tumor microenvironment: From cancer progression to treatment
Corn, K. C., Windham, M. A., & Rafat, M. (2020) · Progress in Lipid Research · doi:10.1016/j.plipres.2020.101055 · Cited by 472 · see citing works
Gong, Y., Ji, P., Yang, Y., Xie, S., Yu, T., Xiao, Y., Jin, M., Ma, D., Guo, L., Pei, Y., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.10.012 · Cited by 472 · see citing works
Metabolic recycling of ammonia via glutamate dehydrogenase supports breast cancer biomass
Spinelli, J. B., Yoon, H., Ringel, A. E., Jeanfavre, S., Clish, C. B., & Haigis, M. C. (2017) · Science · doi:10.1126/science.aam9305 · Cited by 468 · see citing works
Oh, M.-H., Sun, I.-H., Zhao, L., Leone, R. D., Sun, I.-M., Xu, W., Collins, S. L., Tam, A. J., Blosser, R. L., Patel, C. H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci131859 · Cited by 456 · see citing works
“Alternatively, suppressive immune cells, that are metabolically distinct from effector cells, thrive in the TME (1-3).”
BackgroundThe Evasion Mechanisms of Cancer Immunity and Drug Intervention in the Tumor Microenvironment
Kim, S. K., & Cho, S. W. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.868695 · Cited by 473 · see citing works
“Therefore, further research should aim to elucidate the diversity of tumor metabolism in order to develop effective anti-cancer immunotherapy (Hu et al., 2013; Crompton et al., 2015; Hensley et al., 2016; Pavlova and Thompson, 2016; Grzes et al., 2017; Palm et al., 2017; Reid et al., 2017; Badur and au, 2018; Wellenst…”
BackgroundOncolytic virotherapy: basic principles, recent advances and future directions
Lin, D., Shen, Y., & Liang, T. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01407-6 · Cited by 469 · see citing works
“Normally, in glycolysis, glucose is usually fermented into lactic acid under hypoxia, but in tumor cells, such fermentation can also happen under oxygen-sufficient conditions.248 Although this effect greatly sacrifices the efficiency of ATP production, it allows glycolysis and TCA cycle intermediate to participate in…”
BackgroundInfluentialDong, S., Liang, S., Cheng, Z., Zhang, X., Luo, L., Li, L., Zhang, W., Li, S., Xu, Q., Zhong, M., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02229-6 · Cited by 466 · see citing works
“Metabolic reprogramming is one of the important hallmarks of cancer cells [6, 7].”
BackgroundMitochondrial Dynamics in Regulating the Unique Phenotypes of Cancer and Stem Cells
Chen, H., & Chan, D. C. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.05.016 · Cited by 445 · see citing works
“Many cancer cells display the Warburg effect, in which cells predominantly rely on glycolysis over oxidative phosphorylation (OXPHOS), even when oxygen is plentiful (Pavlova and Thompson, 2016; Vander Heiden et al., 2009).”
The microbiome and gynaecological cancer development, prevention and therapy
Łaniewski, P., Ilhan, Z. E., & Herbst‐Kralovetz, M. M. (2020) · Nature Reviews Urology · doi:10.1038/s41585-020-0286-z · Cited by 469 · see citing works
Aspartate is a limiting metabolite for cancer cell proliferation under hypoxia and in tumours
Garcia-Bermudez, J., Baudrier, L., La, K., Zhu, X. G., Fidelin, J., Sviderskiy, V. O., Papagiannakopoulos, T., Molina, H., Snuderl, M., Lewis, C. A., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0118-z · Cited by 442 · see citing works
“As solid tumors frequently outgrow their blood supply, cancer cells reside in nutrient and oxygen poor environments (6, 7).”
BackgroundE3 ubiquitin ligases: styles, structures and functions
Yang, Q., Zhao, J., Chen, D., & Wang, Y. (2021) · Molecular Biomedicine · doi:10.1186/s43556-021-00043-2 · Cited by 435 · see citing works
Oxygen availability and metabolic adaptations
Nakazawa, M. S., Keith, B., & Simon, M. C. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.84 · Cited by 430 · see citing works
Programming CAR-T cells to kill cancer
Labanieh, L., Majzner, R. G., & Mackall, C. L. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0235-9 · Cited by 439 · see citing works
CircRNAs in cancer metabolism: a review
Yu, T., Wang, Y., Fan, Y., Fang, N., Wang, T., Xu, T., & Shu, Y. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0776-8 · Cited by 425 · see citing works
“The tolerable level of ROS not only activates HIF1-α and NRF2 but inhibits protein phosphatases such as PTEN [2].”
BackgroundInfluentialYang, L., Achreja, A., Yeung, T.-L., Mangala, L. S., Jiang, D., Han, C., Baddour, J., Marini, J. C., Ni, J., Nakahara, R., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.10.011 · Cited by 433 · see citing works
“In fact, metabolic interactions of cancer cells with TME have been associated as one of the emerging hallmarks of cancer (Pavlova and Thompson, 2016).”
BackgroundMannose impairs tumour growth and enhances chemotherapy
Gonzalez, P. S., O’Prey, J., Cardaci, S., Barthet, V. J. A., Sakamaki, J.-I., Beaumatin, F., Roseweir, A. K., Gay, D. M., Mackay, G., Malviya, G., et al. (2018) · Nature · doi:10.1038/s41586-018-0729-3 · Cited by 430 · see citing works
Metabolism of Amino Acids in Cancer
Wei, Z. C., Liu, X., Cheng, C., Yu, W., & Yi, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.603837 · Cited by 439 · see citing works
“Metabolic reprogramming is one of the hallmarks of cancer (Pavlova and Thompson, 2016; Revathidevi and Munirajan, 2019; Faubert et al., 2020; Hoxhaj and Manning, 2020; Leone and Powell, 2020).”
BackgroundTranslating gammadelta (γδ) T cells and their receptors into cancer cell therapies
Sebestyén, Z., Prinz, I., Déchanet‐Merville, J., Silva‐Santos, B., & Kuball, J. H. E. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0038-z · Cited by 426 · see citing works
Altered metabolite levels in cancer: implications for tumour biology and cancer therapy
Sullivan, L. B., Gui, D. Y., & Heiden, M. G. V. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.85 · Cited by 406 · see citing works
Phosphoinositide 3-Kinase/Akt Signaling and Redox Metabolism in Cancer
Koundouros, N., & Poulogiannis, G. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00160 · Cited by 420 · see citing works
“(4) Opportunities for therapeutically exploiting redox metabolism in”
BackgroundInfluentialmTORC2 Promotes Tumorigenesis via Lipid Synthesis
Guri, Y., Colombi, M., Dazert, E., Hindupur, S. K., Roszik, J., Moes, S., Jenoe, P., Heim, M. H., Riezman, I., Riezman, H., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.11.011 · Cited by 410 · see citing works
Regulation of cancer cell metabolism: Oncogenic MYC in the driver’s seat
Dong, Y., Tu, R., Liu, H., & Qing, G. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00235-2 · Cited by 405 · see citing works
Zhu, H., Bi, D., Zhang, Y., Kong, C., Du, J., Wu, X., Wei, Q., & Qin, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00831-w · Cited by 412 · see citing works
“To meet the requirements of rapid proliferation, tumor cells utilize glycolysis, even in the presence of oxygen: a phenomenon known as the “Warburg effect”.(235) Thus, any pharmacologic intervention that reduces intratumoral glucose levels may be effective for slowing tumor growth.”
BackgroundEnergy metabolism in health and diseases
Liu, H., Wang, S., Wang, J., Guo, X., Song, Y., Fu, K., Gao, Z., Liu, D., He, W., & Yang, L. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02141-x · Cited by 438 · see citing works
- Authors
- Pavlova, N. N., & Thompson, C. B.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Thompson, Craig B.
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2016-01
- Volume
- 23
- Issue
- 1
- Pages
- 27-47
- ISSN
- 1550-4131 (ISSN-L)
- PMC
- PMC4715268
- OpenAlex
- W2234115940
- Semantic Scholar
- 1e8b6414a84ad7a310eeee976435e51a609d3979
- Cited by
- 5,926
- References
- 254
- Citations by year
- 2026: 576 · 2025: 556 · 2024: 661 · 2023: 678 · 2022: 819 · 2021: 846 · 2020: 601 · 2019: 477 · 2018: 352 · 2017: 252 · 2016: 103 · 2012: 1
- FWCI
- 36.25
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 377 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Cell Metabolism (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute
- Terri Brodeur Breast Cancer Foundation
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- cancer metabolism, metabolic reprogramming, carcinogenesis, glucose uptake, amino acid uptake, nutrient acquisition, glycolysis, TCA cycle intermediates, NADPH production, nitrogen requirements, tumor microenvironment, tumor classification
- MeSH terms
- Animals, Antineoplastic Agents, Biological Transport, Cell Transformation, Neoplastic, Energy Metabolism, Humans, Mutation, Neoplasms, Signal Transduction, Metabolic Networks and Pathways
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-09.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-09.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review